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Little Elongation Complex (lec) And Super Elongation Complex (sec) As
Regulators Of Tdp-43-Associated Neurodegeneration
Abstract
TDP-43 aggregation is the pathological hallmark of amyotrophic lateral sclerosis (ALS) and
frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-TDP). To define pathways
important in TDP-43 proteinopathy, a genetic screen for modifiers of TDP-43-mediated eye degeneration
was conducted in the fruit fly (Drosophila melanogaster). This approach and the following studies in the
fly identified transcriptional elongation factor Ell as a potent dose-dependent modifier. Ell is a shared
component of little elongation complex (LEC) and super elongation complex (SEC). Our studies show that
downregulation of additional components in LEC or SEC partially but consistently ameliorates
TDP-43-associated eye degeneration, implicating both Ell-associated complexes in TDP-43 toxicity. LEC
regulates transcription of RNA Polymerase II (Pol II)-transcribed small nuclear RNAs (snRNAs), while SEC
mainly regulates transcription of select inducible genes harboring paused Pol II including stress-induced
loci. We hypothesized that, in the disease state, TDP-43 increases the activity of LEC and SEC, leading to
enhanced expression of select target genes that contribute to neurodegeneration. Our results support this
hypothesis by showing that select targets of LEC and SEC become upregulated in fly heads expressing
TDP-43 compared to controls. Among upregulated targets, U12 snRNA and a stress-induced long noncoding RNA (lncRNA) Hsr were shown to functionally contribute to TDP-43-induced degeneration in
Drosophila. The increase in U12 snRNA leads to elevated activity of the U12-dependent spliceosome,
assessed by examining U12-dependent splicing events. Among the known U12 targets, the splicing of
genes CG15735, CG16941 and CG11839 were shown to be upregulated selectively by TDP-43. In addition,
the novel target of TDP-43 Hsr was identified by polytene chromosome association of TDP-43 and SEC
components Lilli and Ell in the fly. We extended the findings of Hsr to show that the human orthologue
Satellite III repeat (Sat III) is elevated in both a human cellular disease model of TDP-43 toxicity, and
FTLD-TDP patient tissue. Furthermore, TDP-43 was shown to interact with human ELL2 by coimmunoprecipitation from human HEK293 cells. These findings support a model whereby TDP-43
promotes the LEC and SEC activities through an interaction with ELL2, leading to abnormal activation of
LEC and SEC target genes that contribute to degeneration. These studies reveal the critical roles of Ell
and Ell-associated complexes in TDP-43 toxicity, identify important downstream targets, and provide
potential therapeutic strategies to combat TDP-43-associated neurodegeneration.
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ABSTRACT
LITTLE ELONGATION COMPLEX (LEC) AND SUPER ELONGATION COMPLEX
(SEC) AS REGULATORS OF TDP-43-ASSOCIATED NEURODEGENERATION
Chia-Yu Chung
Nancy M. Bonini

TDP-43 aggregation is the pathological hallmark of amyotrophic lateral sclerosis (ALS)
and frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-TDP). To
define pathways important in TDP-43 proteinopathy, a genetic screen for modifiers of
TDP-43-mediated eye degeneration was conducted in the fruit fly (Drosophila
melanogaster). This approach and the following studies in the fly identified
transcriptional elongation factor Ell as a potent dose-dependent modifier. Ell is a shared
component of little elongation complex (LEC) and super elongation complex (SEC). Our
studies show that downregulation of additional components in LEC or SEC partially but
consistently ameliorates TDP-43-associated eye degeneration, implicating both Ellassociated complexes in TDP-43 toxicity. LEC regulates transcription of RNA
Polymerase II (Pol II)-transcribed small nuclear RNAs (snRNAs), while SEC mainly
regulates transcription of select inducible genes harboring paused Pol II including stressinduced loci. We hypothesized that, in the disease state, TDP-43 increases the activity
of LEC and SEC, leading to enhanced expression of select target genes that contribute
to neurodegeneration. Our results support this hypothesis by showing that select targets
of LEC and SEC become upregulated in fly heads expressing TDP-43 compared to
controls. Among upregulated targets, U12 snRNA and a stress-induced long non-coding
RNA (lncRNA) Hsrw were shown to functionally contribute to TDP-43-induced
iv

degeneration in Drosophila. The increase in U12 snRNA leads to elevated activity of the
U12-dependent spliceosome, assessed by examining U12-dependent splicing events.
Among the known U12 targets, the splicing of genes CG15735, CG16941 and CG11839
were shown to be upregulated selectively by TDP-43. In addition, the novel target of
TDP-43 Hsrw was identified by polytene chromosome association of TDP-43 and SEC
components Lilli and Ell in the fly. We extended the findings of Hsrw to show that the
human orthologue Satellite III repeat (Sat III) is elevated in both a human cellular
disease model of TDP-43 toxicity, and FTLD-TDP patient tissue. Furthermore, TDP-43
was shown to interact with human ELL2 by co-immunoprecipitation from human HEK293
cells. These findings support a model whereby TDP-43 promotes the LEC and SEC
activities through an interaction with ELL2, leading to abnormal activation of LEC and
SEC target genes that contribute to degeneration. These studies reveal the critical roles
of Ell and Ell-associated complexes in TDP-43 toxicity, identify important downstream
targets, and provide potential therapeutic strategies to combat TDP-43-associated
neurodegeneration.
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CHAPTER 1 : INTRODUCTION

THE ROLES OF ELL-CONTAINING TRANSCRIPTIONAL ELONGATION COMPLEXES
IN TDP-43-ASSOCIATED NEURODEGENERATION

1

ALS/FTD and TDP-43
Amyotrophic lateral sclerosis (ALS; OMIM no. 105400) and frontotemporal dementia
(FTD; OMIM no. 600274) are two neurological disorders with distinct clinical features yet
share common pathogenic mechanisms 1-4. ALS is the most common motor neuron
disease, resulting from loss of upper and lower motor neurons in the motor cortex, the
brainstem and spinal cord, which leads to fatal paralysis. FTD is the second most
common cause of early onset dementia, caused by progressive neuron death in the
frontal and temporal lobes. This results in changes in behavior, personality and/or
language. Increasingly, evidence indicates that ALS and FTD may be within the same
disease spectrum. First, about 15% of ALS patients develop the symptoms of FTD and
vice versa 5-7. Second, genetic mutations in shared genes link these two diseases 1,2,8.
Among the genes bearing causal mutations for both diseases, TAR DNA-binding protein
43 (TDP-43) further connects these two diseases. In 97% of ALS and 45% of FTD
(FTLD-TDP/FTLD-U) patients, TDP-43 was identified to be the major component of
aggregates in the central nervous system 9,10. In the neurons and glia containing TDP-43
inclusions, physiological diffused nuclear TDP-43 is cleared and cytoplasmic aggregates
of full length and truncated TDP-43 are observed with abnormal hyperphosphorylation
and ubiquitination 9,10.

TDP-43 is a DNA and RNA binding protein with the molecular weight of 43 kDa, which
was discovered and named for its ability to bind transactive response (TAR) element of
human immunodeficiency virus type 1 (HIV-1) 11. The total length of TDP-43 is 414
amino acids. It contains a N-terminal domain (NTD) including a nuclear localization
signal, two RNA recognition motifs (RRMs) with a nuclear export signal within the
second RRM domain and a C-terminal domain (CTD). The CTD containing QN-rich
2

residues is implicated in the aggregation propensity of TDP-43 and is where most of
ALS/FTD-associated mutations are located 12-14. TDP-43 is involved in various cellular
processes, including splicing regulation, microRNA processing, RNA stability, gene
expression, RNA translocation between nucleus and cytoplasm, stress granule
regulation, cell proliferation and apoptosis 13,15. Research in different disease models
shows that both upregulation and depletion of TDP-43 leads to neuron loss, indicating
that a balanced level of TDP-43 is critical in the nervous system 13,16,17.

Drosophila as a powerful genetic model system
To understand the mechanisms of TDP-43 protein pathology, animal models have been
established. Each disease model has its strength, revealing disease mechanisms from
different angles. Drosophila melanogaster has a short lifespan, conserved genes and
pathways with humans as well as powerful genetics, providing an extraordinary system
for unbiased genetic screens to identify novel pathways. The life cycle of each
generation of the fruit fly is about 10 days; therefore, large numbers of progeny for
research can be obtained in a short period of time. Moreover, although the genome size
of Drosophila (1.2 x 108 base pairs) is much smaller than the human genome size (3.3 x
109 base pairs), around 70% of known human disease genes have fly orthologs in the fly
based on sequence analysis 18,19. This homology provides an opportunity for elucidation
of mechanisms that may be involved in human disease. In fact, the smaller genome size
of the fly reduces the complexity of gene redundancy of mammalian systems, and allows
quicker and easier interpretation for loss of function studies.

3

The advantages of using Drosophila as a model organism also include a comprehensive
and versatile toolbox for genetic manipulation. The fruit fly has been used as a model
organism for more than 100 years, and tools have been developed to manipulate the
expression of fly genes 20,21. For example, the GAL4-UAS bipartite system is widely used
for gene manipulation, allowing spatial and temporal expression of exogenous genetic
constructs 22,23. The system is composed of two parts. In one construct, a tissue specific
promoter drives the expression of the yeast transcription factor GAL4; in the second
construct, a desired transgene is combined with an upstream activation sequence
(UAS), which can be activated by the GAL4. Therefore, the transgene will be selectively
expressed in the tissue of interest. Additional regulation and modification of GAL4 can
be used to control the temporal expression. For instance, Gal80ts, a temperature
sensitive inhibitor of the GAL4 protein, is used to turn on the expression system at higher
temperature (>30°C), at which the inhibition by Gal80ts is repressed 24. Another method
is by using a ligand-inducible GAL4 chimera, GAL4-progesterone receptor fusion
(GeneSwitch), which is activated in the presence of the drug mifepristone (RU486) 25.

Over time, the fly community has generated comprehensive collections of mutants and
transgenic fly lines. The Bloomington Drosophila Stock center at Indiana University
(BDSC) held 67,634 stocks at the end of 2017, including a genome-wide RNAi
collection. There are also other Drosophila stock centers, such as the Vienna Drosophila
Research Center (VDRC), Kyoto Stock Center (DGRC), Fly Stocks of National Institute
of Genetics (NIG-FLY) and Zurich ORFome Project (FlyORF). Together, these stock
centers provide an accessible resource allowing manipulation of almost every gene. The
extensive resources and toolbox make Drosophila an excellent model organism for
4

genetic screen. Such screens have highlighted various factors in fly disease models of
neurodegenerative disorders 26,27.

Fly models for TDP-43 toxicity
The TDP-43 pathologies, which includes nuclear clearance and cytoplasmic
accumulation of TDP-43, suggests the possibility that degeneration may be caused by
loss-of-function in the nucleus and/or gain-of-function in the cytoplasm 9,10. Different fly
diseases models have been used to elucidate mechanisms in TDP-43-associated
neurodegeneration, including depletion and overexpression of Drosophila TDP-43
(TBPH) 28-31, and expression of different forms of human TDP-43 32-38. Downregulation of
TBPH in the fly leads to neuronal defect and shortened lifespan 28-31, indicating that
normal function of TBPH is important for neuronal function and supporting the loss-offunction model. Fly TBPH and human TDP-43 share conserved domains, and sequence
analysis shows 59% amino acid identity between them 39. Both proteins bind to UG
repeat sequences 39. Furthermore, the phenotype caused by TBPH depletion can be
rescued by human TDP-43 28, indicating functional conservation between fly and human
TDP-43. Ectopic expression of TBPH or human TDP-43 also recapitulates features of
human patients, such as neuron loss, motor disability and decreased lifespan 30-35,37,38.
Furthermore, at the molecular level, expression of fly and human TDP-43 can lead to
cytoplasmic TDP-43 aggregation, and ubiquitinated and phosphorylated forms of TDP43 aggregates, mimicking human molecular pathologies and potentially modeling the
gain-of-function toxicity 31,33,36-38. Therefore, dissecting the pathways involved in
neurodegeneration in these different disease models may reveal mechanistic insights of
TDP-43 proteinopathy in human disease.
5

In order to elucidate novel and important factors involved in TDP-43-associated
neurodegeneration, studies in our lab using the Drosophila eye as a platform for genetic
screening. We identified Drosophila eleven-nineteen lysine-rich leukemia (Ell; also
known as Su(Tpl)) as a potential modifier of TDP-43-mediated degeneration. The
Drosophila eye provides a platform for high throughput genetic screening since it is a
nonessential organ for survival. The fly compound eye is a simple and delicate nervous
system composed of thousands of neuronal and nonneuronal cells 40. The basic unit is
ommatidium, which contains 8 photoreceptor neurons and surrounded by 4 lenssecreting cone cells and 2 primary pigment cells. In between each ommatidium, there
are 12 accessory cells. Because the structure of the eye is highly ordered, degeneration
and cell death can be easily observed as morphological phenotypes, such as rough eye,
small eye or change of pigmentation. Expression of the human TDP-43 in fly eye leads
to disruption of eye integrity 37,38, and studies in our lab found that downregulation of Ell
strongly suppresses the degeneration caused by TDP-43 toxicity.

Transcription elongation factor: Ell
RNA Polymerase II (Pol II) is a 12-subunit enzyme that synthesizes protein-coding
mRNAs and non-coding RNAs (ncRNAs). The process is tightly regulated at different
stages of transcription, including initiation, pausing, elongation and termination. More
and more attention has been brought toward the understanding of pausing regulation.
After forming the preinitiation complex, Pol II can pause and accumulate in the proximal
region (30-60 nucleotides downstream of the transcription start site) 41-43. The release of
paused Pol II into productive elongation requires the kinase, positive transcription
elongation factor b (P-TEFb). P-TEFb is composed of the cyclin-dependent kinase 9
6

(CDK9) and cyclin T1 (CYCT1) or CYCT2. It can phosphorylate negative elongation
factor (NELF), 5, 6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB) sensitivity-inducing
factor (DSIF) and Pol II on the carboxy-terminal domain (CTD). NELF and DSIF are
factors working together to set up paused Pol II at the promoter-proximal region.
Phosphorylation of these 3 factors leads to dissociation of NELF from Pol II and
productive transcription elongation.

Indicated by large scale genomic studies, the release of paused Pol II into elongation is
an important rate-limiting step of gene expression, potentially for all active genes 44.
Depending on the methods and cell type, 40%-70% of active genes show accumulation
of Pol II at the promoter proximal region. However, studies using drug treatments
inhibiting P-TEFb and genome-wide sequencing methods show that prevention of Pol II
from releasing halts almost all transcription. These data suggest that P-TEFb dependent
pausing regulation may be a highly variable rate-limiting regulatory step for all active
genes. The importance of pausing regulation has been highlighted by research
investigating its role on transcription subjected to regulatory control and stimuli, such as
differentiation signals and heat stress 41-43. Transcriptional pausing regulation allows
rapid induction of transcription as well as enabling fine-tuning of gene activation. The
paused Pol II is transcriptionally-engaged and awaiting signaling events, such as
developmental cues, physiological signals and stress response. Upon stimulation,
poised Pol II can activate gene expression rapidly and serve as a transcription
checkpoint for precise and synchronized gene activation upon stimulation.

7

Several factors regulating transcriptional elongation have been identified by in vitro
biochemical assays; these factors include ELL 45. ELL was isolated from rat liver nuclei
extract as a factor that promotes the catalytic rate of transcription elongation by
repressing transient pausing of Pol II 46. Human ELL is a protein containing 621 amino
acids, which is also capable of simulating transcription elongation like the rat ELL protein
46

. Following the purification and investigation of ELL, two additional ELL-related

proteins, ELL2 and ELL3, were also characterized in mammalian cells 47,48. Through
sequence comparison, ELL2 and ELL3 were identified and cloned for in vitro
characterization. The ELL2 open reading frame (ORF) encodes a 640-amino acid
protein 48, while ELL3 ORF encodes a protein containing 397-amino acids, which is
testis specific based on Northern blot analysis in different tissues 47. The alignment of all
three proteins by CLUSTAL O (1.2.4) multiple sequence comparison is shown in Figure
1-1. Analysis by Clustal 12.1 shows that ELL and ELL2 share 49.43% identity; ELL and
ELL3 share 32.9% identity; ELL2 and ELL3 share 31.97% identity (Table 1-1).
Biochemically, all three ELL family proteins can increase the catalytical rate of Pol II
transcription elongation 46-48. In vivo studies indicate that the function of ELL3 is distinct
from the other two. By using mouse embryonic stem cells, ELL3 was shown to occupy
enhancer regions for priming of gene activation for proper differentiation 49.

8
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Figure 1-1. Alignment of human ELL, ELL2, ELL3 and Drosophila Ell
Comparison of protein sequences of ELL, ELL2, ELL3 and fly Ell by CLUSTAL O
(1.2.4) multiple sequence comparison.
10

Table 1-1. Percentage identity matrix created by Clustal 12.1
Human ELL
Human ELL2
Human ELL3
Human ELL
100.00
49.43
32.90
Human ELL2
49.43
100.00
31.97
Human ELL3
32.90
31.97
100.00
Fly Ell
30.38
28.73
20.73

Fly Ell
30.38
28.73
20.73
100.00

The ELL family proteins are highly conserved in mammal and nonmammal species 50. In
Drosophila, Ell is the orthologue with a conserved function in promoting Pol II elongation.
Ell was cloned and shown to increase catalytic rate of Pol II elongation in vitro 51.
Although the neighbor-joining phylogenic tree indicates that fly Ell is equally divergent
from human ELL family proteins (Figure 1-2), according to sequence alignment, fly Ell is
more similar to human ELL (30.38% identity) and ELL2 (28.73% identity) than ELL3
(20.73% identity) (Figure 1-1 and Table. 1-1). Ell was also shown to regulate heat shock
gene induction upon heat stress in vivo. By chromosome
immunostaining in the fly salivary gland, Ell was found to
co-localize with active elongating Pol II under heat
stress treatment at heat shock loci, which have been
used as an established model for investigating the
regulation of paused Pol II in Drosophila 51,52.

Figure 1-2. A phylogenic
tree for human ELL family
proteins and fly Ell
A neighbor-joining phylogenic
tree shows that human ELL
and ELL2 are less divergent.

The heat shock response is highly conserved for the protection of cells from a heat
stress-induced proteotoxic environment 53,54. Upon heat shock and other stresses, heat
shock genes are rapidly and strongly induced. Heat shock proteins encoded by these
genes are molecular chaperones that maintain proteostasis and promote cell survival.
Research on heat shock genes in Drosophila is one of the early studies that indicates
the existence of a transcriptional elongation control mechanism. In Drosophila cells, Pol
11

II was found to be transcriptionally engaged and form a nascent RNA chain of about 25
nucleotides at one of the major heat shock genes, HSP70, prior to heat shock treatment
55

. The paused Pol II can be released to synthesize the full-length HSP70 transcription

unit upon heat stress treatment 56. In the fly, staining of the salivary gland polytene
chromosomes is often used for study of heat shock response. In the salivary gland of the
3rd instar larvae, the chromosomes go through multiple rounds of replication without cell
division, resulting in giant polytene chromosomes. This provides a unique opportunity to
study the relationship between chromatin structure and transcription. Upon heat shock,
stress genes are actively expressed and causes heat shock “puffs” on the polytene
chromosomes, such that the major heat shock loci and encoded genes have been well
characterized and identified 57-63. Regulations of the transcription elongation of heat
shock genes is conserved in mammals 64,65.

Ell is involved in SEC and LEC
Ell has been reported to be part of two elongation complexes: super elongation complex
(SEC) and little elongation complex (LEC) 66, and these complexes are highly conserved
from Drosophila to human (Table 1-2 and Figure 1-2). ELL was first identified and
named as a gene that fuses to mixed-lineage leukemia (MLL) in acute myeloid leukemia
50

. MLL is located at chromosome 11 band q23, where aberrant translocation occurs

frequently in hematologic malignancies. In these cases, the abnormal chromosome
translocation leads to an in-frame fusion of the N terminus of MLL to the C-terminal part
of various proteins with very little sequence similarity. Frequent fusion partners of MLL
include ELL, AFF1, AF9, ENL and AF10 50,67. To better understand the relationship
among these factors, the Shilatifard group generated cell lines expressing major MLL12

chimera complexes and purified them for mass spectrometry analysis. This approach led
to the isolation of the SEC 68. The composition of SEC was also investigated and
reported using tagged normal proteins 69. The isolation of SEC was also reported by the
Zhou and the Kiernan groups through purification of transcription factors associated with
Tat protein of human immunodeficiency virus type 1 (HIV-1) virus, which hijacks host
transcription machinery for promoting transcription elongation for viral gene expression
70,71

.

Table 1-2. Conserved genes involved in SEC and LEC from Drosophila to human
Super Elongation Complex (SEC)
Drosophila melanogaster
Homo sapiens
Gene

CG#

Gene
ELL/ELL1

NCBI Gene ID
8178

Su(Tpl)/Ell

CG32217

ELL2
ELL3

22936
80237

Eaf

CG11166

EAF1
EAF2

85403
55840

AFF1
AFF2
AFF3
AFF4
MLLT1/ENL
MLLT3/AF9
CDK9
CCNT1

4299
2334
3899
27125
4298
4300
1025
904

lilli

CG8817

ear

CG4913

Cdk9
CycT

CG5179
CG6292

Little Elongation Complex (LEC)
Drosophila melanogaster
Homo sapiens
Gene
CG#
Gene
NCBI Gene ID
Su(Tpl)/Ell
CG32217
ELL/ELL1
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Figure 1-3. Schematics of SEC and LEC in fly and mammals
SEC and LEC are highly conserved from Drosophila to mammals.

The components of SEC include ELL family proteins ELL, ELL2 and ELL3, AF4/FMR2
family member 1 (AFF1; also known as AF4), AFF4, eleven-nineteen leukemia (ENL)
and ALL1-fused gene from chromosome 9 (AF9), and P-TEFb 66. AFF4 is the scaffold
protein that directly interacts with P-TEFb, ENL/AF9 and ELL family proteins and is
essential for SEC assembly 68. The conservation of SEC in Drosophila was reported by a
study that used a flag-tagged C terminus of Ell in fly S2 cells. Isolation by flag-affinity
chromatography and analysis by mass spectrometry identified the fly SEC, which
contains Ell (human ELL, ELL2 and ELL3-related), Lilli (human AFF1/4-related), Ear
(human ENL/AF9-related) and P-TEFb 69,72 (Figure 1-3). P-TEFb is the kinase
responsible for releasing paused Pol II. Containing P-TEFb, SEC has been shown to
activate transcription through pausing regulation for genes involved in immediate
responses, including developmental genes and stress-induced genes 68,73 (Figure 1-4).
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Figure 1-4. The function of SEC
SEC activates transcription,
mostly through pausing regulation,
for genes involved in immediate
responses

Identified targets of SEC include developmental genes. One study that identified the
SEC complex through MLL-chimera also showed that in leukemia cell lines, SEC
component AFF4 is responsible for the expression of developmental genes HOXA9 and
HOXA10; these genes are often upregulated in cells bearing an MLL translocation 68.
This study suggests that in leukemia, the fusion of MLL and SEC components leads to
premature release of paused Pol II and increased levels of developmental genes. The
role of SEC in regulating transcription elongation on developmental genes was also
demonstrated in mouse embryonic cells in response to retinoic acid (RA) and human
HCT-116 cells in response to serum 73. These results show that SEC is responsible for
the rapid induction of a small subset of genes upon exposure to developmental signals.
These genes have paused Pol II prior to stimulation, except one gene, Cyp26a1, whose
induction requires SEC in the absence of paused Pol II, indicating there might be other
mechanisms for rapid induction of transcription that involves SEC.

Another group of identified SEC targets are heat shock genes. Given that heat shock
gene regulation is a well-established model for pausing regulation and that SEC is
involved in the regulation of transcriptional pausing, the regulation of heat shock genes
by SEC was tested. Chromosome immunostaining in Drosophila salivary gland showed
15

that the major component of SEC, Lilli, colocalizes with Ell and elongating Pol II on the
chromosomes 68. After heat shock treatment, Lilli co-localizes with Ell on the heat shock
loci together with elongating Pol II, suggesting that SEC releases paused Pol II on heat
shock genes 68. Studies using chromatin immunoprecipitation and quantitative PCR
(ChIP-qPCR) and qPCR confirmed that the scaffold protein of SEC, AFF4, is also bound
to HSP70 and is required for its induction upon heat stress 68.

In mammals, besides the SEC complex, there are 2 related complexes: SEC-like 2
(SEC-L2) and SEC-like 3 (SEC-L3) (66,72 and Figure 1-3). In mammals, except AFF1 and
AFF4 which are involved in SEC, the AFF family also includes AFF2 (also known as
FMR2) and AFF3 (also known as LAF4). These proteins share conserved N-terminal
and C-terminal regions. SEC-L2 and SEC-L3, containing AFF2 and AFF3 respectively,
were biochemically purified from human cells. Similar to SEC, SEC-like complexes also
contain the kinase P-TEFb and ENL or AF9, but ELL family proteins were not identified
as components involved. Genome wide studies showed that SEC, SEC-L2 and SEC-L3
regulate different sets of genes 72. In addition, although all 3 complexes can
phosphorylate Pol II CTD in vitro, only SEC is responsible for the induction of Hsp70
under heat shock in vivo 72. These different complexes in mammals are predicted to
expand the regulatory ability of cells in response to different cellular signals.

Ell is also identified to be involved in LEC (Figure 1-5). In the study identifying
components that interact with Drosophila Ell, two proteins Ice1 and Ice2 were isolated as
well as the components of SEC (Ice stands for “interacts with the C terminus of Ell”) 69.
Ice1 and Ice2 interact with Ell and Eaf, but not other components of SEC. This led to the
identification of LEC, which is composed of Ell, Eaf, Ice1 and Ice2. Ell is implicated in
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enhancing transcription elongation of target genes of LEC 74. The major transcriptional
targets of LEC are Pol II-transcribed small nuclear RNAs (snRNAs) (Figure 1-5). ChIPseq studies using Ell and Ice antibodies identified snRNA genes as sites of LEC and Pol
II enrichment 69. RNA sequencing (RNA-seq) with Ell and Ice1 depletion also show that
Pol II-transcribed snRNA genes are the most altered class of genes in LEC
downregulated cells 69.

Figure 1-5. The function of LEC
LEC is responsible for the
transcription of snRNAs.

snRNAs are short non-coding RNAs that form small nuclear ribonucleoprotein particles
(snRNPs). snRNPs further assemble with numerous proteins into the spliceosomes,
functioning in pre-mRNA splicing 75. Splicing is an essential step of gene expression,
which can also increase the number of unique proteins from a single pre-mRNA species.
Splicing is catalyzed by the spliceosomes of which there are two types: the U2dependent spliceosome (also known as the major spliceosome), which is responsible for
more than 99% of the splicing events, and the U12-dependent spliceosome (also known
as the minor spliceosome), which is less abundant. The U2 spliceosome includes
snRNPs: U1, U2, U4, U5 and U6. The U12 spliceosome is composed of U11, U12,
U4atac, U5 and U6atac snRNPs 76,77 (Table 1-3). In addition to the snRNAs involved in
the minor or major spliceosomes, there is another snRNA U7, which is involved in the
maturation of replication-dependent histone mRNA 78. U1, U2, U4, U4atac, U5, U7, U11
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and U12 are transcribed by Pol II, whereas U6 and U6atac are generated by RNA
polymerase I (Pol I).
Table 1-3. Major vs Minor spliceosome snRNAs
Spliceosome U2-dependent/major
U12-dependent/minor
U1
U11
U2
U12
snRNAs
U5
U5
U4
U4atac
U6
U6atac
The composition and function of LEC is highly conserved from Drosophila to mammals.
The orthologues of Ice1 and Ice2 in human are ICE1 and ICE2, respectively 69. Based
on biochemical purification, human LEC is composed of ELL family proteins,
EAF1/EAF2, ICE1 and ICE2 69. In human HCT-116 cells, a protein ZC3H8 was also copurified with LEC 74. ICE1 is the scaffold protein which is critical for LEC assembly,
proper localization of LEC in subnuclear bodies as well as downstream target expression
74

. ChIP-seq using HCT-116 cells shows that LEC subunits occupy Pol II-transcribed

snRNA genes, and consistently RNA-seq study found that downregulation of ICE1 leads
to a global reduction of snRNA expression 74. Pol II ChIP-seq analysis, comparing cells
with ICE1 depletion to control cells, further shows that depletion of ICE1 decreases Pol II
occupancy on LEC-bound snRNA genes 74.

Implications of the roles of LEC and SEC in diseases
The disrupted function of SEC has been directly associated with human disorders
including immunodeficiency, cancer and developmental syndromes 79-82. SEC is also
critical for HIV-1 replication 70,71. In HIV-1 gene expression, elongation of paused Pol II
near the transcription start site is a major rate-limiting step. The Tat protein encoded by
HIV-1 is an RNA binding protein, which binds to Tat response element (TAR). Together,
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they recruit SEC to the 5’ end of all viral transcripts to produce full length products.
Another disease associated with disrupted SEC activity is leukemia 68. As discussed
previously, many components of SEC have been found as translocation partners with
MLL in disease. In leukemia cells carrying an MLL translocation, depletion of the
essential component of SEC AFF4 results in loss of HOXA9 expression, which is a key
target of MLL fusion proteins. The involvement of SEC in MLL fusion proteins suggests
that the regulation of transcription elongation may be disrupted and contribute to MLLrearranged leukemias. Germline gain-of -function mutations in AFF4 were identified to
be the cause of the developmental disorder CHOPS syndrome 83. The name CHOPS is
an abbreviation for features of the disease, including cognitive impairment, coarse
facies, heart defects, obesity, pulmonary involvement, short stature and skeletal
dysplasia. ChIP-seq analysis suggests that in the disease, transcriptional elongation is
disturbed by altered binding of AFF4 and cohesin on chromosomes 83.

Although neither LEC or SEC has been implicated in neurodegenerative disorders,
misregulations of targets of LEC and SEC have been reported in neurodegeneration. As
introduced and discussed before, the targets of LEC are Pol II-transcribed snRNAs,
which are involved in splicing. Global splicing alterations have been observed by
genome-wide analysis in both FTD and ALS patients 84,85. Furthermore, in ALS patient
brain tissue and human cell disease models, the levels of several snRNAs are reported
to be altered, with both higher and lower levels 86,87. Onodera’s group showed that the
levels of U1, U2, U4atac and U6atac were significantly decreased in SH-SY5Y
neuroblastoma cells treated with TDP-43 siRNA compared to control cells 86. They also
showed that U12 levels are decreased in ALS affected tissues, including spinal cord,
motor cortex and thalamus, but not in unaffected tissues, including cerebellum, kidney
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and muscle. However, Yamanaka’s group reported that U4, U5 and U6 are upregulated
in SH-SY5Y cells with TDP-43 downregulation compared to control cells, and that
several snRNAs including U1, U2, U4, U5 U11 and U12 are upregulated in spinal cord
tissue of ALS patients 87. These studies indicate that in TDP-43-associated diseases
snRNA levels and the spliceosome functions are disrupted, although there are
discrepancies on the changes observed.

The minor spliceosome was discovered about a decade later than the discovery of the
major spliceosome and has been studied less; however, more attention has been
brought to it because of its involvement in diseases including neurodevelopmental and
neurodegeneration disorders 88,89. A point mutation in RNU12 encoding the U12 snRNA
has recently been reported to be associated with early onset cerebellar ataxia (EOCA).
EOCA is characterized by progressive cerebellar ataxia, brisk tendon reflexes and
sensory loss. The mutation (84C>T) is located on one of the stem loop structures and is
predicted to weaken the stem-closing base pairing and potentially affect protein
interactions and spliceosome assembly 90. Other known diseases associated with
defects in minor spliceosome components include Microcephalic Osteodysplastic
Primordial Dwarfism type I/Taybi-Linder Syndrome (MOPD1/TALS), Myelodysplastic
Syndrome (MDS), Roifman syndrome (RFMN), Lowry Wood Syndrome (LWS) and
Isolated Growth Hormone Deficiency (IGHD) 89,91-95. Three of these diseases
(MOPD1/TALS, RFMN and LWS), share clinical features of abnormal brain development
related to cephalon-skeletal dysplasia, intrauterine and postnatal growth retardation and
microcephaly.
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The minor spliceosome is also associated with neurodegeneration. In addition to ALS,
another neurodegenerative disease caused by death of motor neurons spinal muscular
atrophy (SMA), has also been linked to dysfunction of the minor spliceosome. SMA
results from mutations in the SMN gene, which leads to decreased levels of the SMN
protein. SMN is essential for assembly of Sm-class snRNPs, including U1, U2, U4,
U4atac, U5, U7, U11 and U12 snRNPs 96. Studies using different SMA models have
shown preferential decrease of minor snRNP levels 97-100, implying that the alteration of
splicing regulated by the minor spliceosome may contribute to the SMA phenotype.

Heat shock genes are one group of identified and characterized targets of SEC. As
neurodegenerative diseases are associated with the accumulation of misfolded proteins,
the important role of protein folding machinery maintaining proteostasis has been
indicated in neurodegeneration through different studies 101,102. Among these,
misregulation of the heat shock response has been reported to be associated with TDP43 proteinopathy 103-105. By using a human cell disease model of TDP-43 toxicity,
Hsiang-Yu el al. show that Hsp90 inhibitor 17-AAG, which inhibits Hsp90 activity but
activates HSF-1, Hsp27 and Hsp70, prevent TDP-43 aggregation caused by reactive
oxygen species (ROS) 104. In another study, Han-Jou el al. demonstrated in a TDP-43
cellular model that promoting the heat shock response by expression of the master
regulator HSF1 leads to a decrease of insoluble TDP-43 aggregates and improves cell
survival 105. In recent work by Berson et al. using fruit fly and human cell models, the
induction of several heat shock genes was found to be reduced in these disease models,
and upregulation of Hsc4 and Hsp68 suppressed eye degeneration caused by TDP-43
toxicity 103. These studies implicate a potential therapeutic role of the heat shock
response in TDP-43-mediated neurodegeneration.
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In Drosophila, among the heat shock genes, which typically encode proteins, one gene
encodes a long non-coding RNA (lncRNA): heat shock response RNA omega (Hsrw) 106.
The Hsrw locus is composed of 2 exons, which are separated by an intron and followed
by tandem repeats of 280 bp units. Nuclear and cytoplasmic lncRNAs named Hsrw-n
and Hsrw-c are produced from this locus. Hsrw is induced dramatically by heat shock
and is required for normal development and for survival after heat stress 106,107. Hsrw-n
together with various proteins forms specific nuclear structures named omega speckles
106

, which are thought to serve as dynamic storage sites for RNA-processing and

associated proteins. Hsrw is also involved in other pathways potentially functioning in
maintenance of cellular homeostasis 106. In human cells, the functional orthologue of
Hsrw is the Satellite III repeat RNA (Sat III) 108. Sat III is encoded by the Sat III repeat
sequences mainly located in the pericentrimeric region of human Chromosome 9 109.
The size of Sat III repeat RNA has been reported to be 2-5 kb, with the basic repeat unit
of Sat III being a pentamer sequence GGAAT, which can be interrupted by the
terminator sequence CAAC(C/A)CGAGT 110. Like Hsrw, Sat III is induced by heat stress
and forms a comparable nuclear structure called the nuclear stress body (nSB) at the
site of synthesis 109. The roles of these heat stress-induced non-coding RNAs in
neurodegenerative diseases remain to be explored.

The new findings of the thesis adding to the field
The main findings of my thesis work include: 1) the identification of Ell and Ell-containing
transcription elongation complexes LEC and SEC as modifiers of TDP-43 toxicity in the
fly. 2) demonstration that the levels of several LEC target snRNAs are upregulated upon
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TDP-43 expression including U12, which is functionally involved in TDP-43 toxicity. 3)
that splicing of select U12-dependent spliceosome targets are elevated in TDP-43 fly
disease model. 4) that TDP-43 co-localizes with SEC specific component Lilli on a
chromosome locus encoding a stress-induced lncRNA Hsrw. 5) that Hsrw is identified as
abnormally elevated and functionally important to TDP-43-mediated degeneration. 6)
that the human orthologue of Hsrw ,Sat III, is increased in human cells with TDP-43
expression and in FTLD-TDP-43 patient tissue. 7) that TDP-43 physically interacts with
one of the human orthologues of Ell, ELL2.

These findings suggest a model in which TDP-43 promotes the activities of LEC and
SEC through interaction with ELL2, leading to the upregulation of specific targets of LEC
and SEC. This upregulation results in misregulation of splicing and cell homeostasis and
contributes to TDP-43-associated neurodegeneration (Figure 1-6). These findings reveal
important roles of LEC and SEC in TDP-43 toxicity and link transcription elongation
complexes to neurodegeneration for the first time, identify important downstream targets
and provide potential therapeutic insights for TDP-43-mediated neurodegenerative
diseases.
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Figure 1-6. The model for the roles of LEC and SEC in TDP-43-mediated
neurodegeneration
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CHAPTER 2: MANUSCRIPT

ABERRANT ACTIVATION OF NON-CODING RNA TARGETS OF TRANSCRIPTIONAL
ELONGATION COMPLEXES CONTRIBUTES TO TDP-43 TOXICITY
Chia-Yu Chung, Amit Berson, Jason R. Kennerdell, Ashley Sartoris, Travis Unger, Sílvia
Porta, Hyung-Jun Kim, Edwin R. Smith, Ali Shilatifard, Vivianna Van Deerlin, Virginia MY Lee, Alice Chen-Plotkin, and Nancy M. Bonini

This chapter is a manuscript in press at Nature Communications.
The contributions of CYC are: 1) verification of the suppression effects of SEC components by
detailed characterizations of the suppression effect and by various control experiments in the fly.
2) raising and testing the hypothesis that both SEC and LEC are involved in TDP-43 toxicity. 3)
demonstration of the involvement of LEC in TDP-43-mediated eye degeneration 4) demonstration
of Ell as a dose-dependent modifier by showing that upregulation of Ell enhances TDP-43-caused
eye degeneration. 5) characterization of Ell as a modifier in the fly nervous system. 6)
identification of important downstream targets of LEC and SEC, and demonstration of the
functional involvement of these targets in fly disease models. 6) extension of the findings from fly
disease models to a human cell disease model and FTLD-TDP patient tissues by developing
qPCR primers and assessing the human repetitive RNA Sat III in RNA samples collected by
collaborators. 7) determination of the RNA and protein levels of human ELL and ELL2 using
samples from a human cell disease model and/or human patient tissues (RNA samples were
collected by collaborators) 8) demonstration of the interaction of TDP-43 and human ELL2 using
human HEK293 cells. 9) all figure panels except Fig 3c,d and Supplementary Data 1. 10)
preparation of the manuscript under the supervision of Dr. Bonini.
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Abstract
TDP-43 is the major disease protein associated with amyotrophic lateral sclerosis (ALS)
and frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-TDP). Here
we identify the transcriptional elongation factor Ell—a shared component of little
elongation complex (LEC) and super elongation complex (SEC)—as a strong modifier of
TDP-43-mediated neurodegeneration. Our data indicate select targets of LEC and SEC
become up-regulated in the fly ALS/FTLD-TDP model. Among them, U12 snRNA and a
stress-induced long non-coding RNA Hsrω, functionally contribute to TDP-43-mediated
degeneration. We extend the findings of Hsrω, which we identify as a chromosomal
target of TDP-43, to show that the human orthologue Sat III is elevated in a human
cellular disease model and FTLD-TDP patient tissue. We further demonstrate an
interaction between TDP-43 and human ELL2 by co-immunoprecipitation from human
cells. These findings reveal important roles of Ell-complexes LEC and SEC in TDP-43associated toxicity, providing potential therapeutic insight for TDP-43-associated
neurodegeneration.
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Introduction
Amyotrophic lateral sclerosis (ALS; OMIM no. 105400) is the most common motor
neuron disease, resulting from loss of motor neurons in the motor cortex, brainstem and
spinal cord, whereas frontotemporal dementia (FTD; OMIM no. 600274) is characterized
by progressive changes in behavior, personality, and/or language due to gradual
deterioration of the frontal and temporal lobes. Despite differences in primary sites of
neurodegeneration, these two diseases share neuropathological and genetic
commonalities as well as clinical overlap 5,6. TAR DNA binding protein 43 (TDP-43) is
the major component of inclusion bodies in most ALS and in half of FTD known as
FTLD-TDP 9,10. Both depletion and upregulation of TDP-43 cause neuronal loss,
indicating that TDP-43 levels are critical in the brain 13,16. TDP-43 is an RNA-binding
protein with many functions in RNA regulation and metabolism and is one of a number of
RNA binding proteins associated with ALS and FTD 13,111,112. This leads to an RNA
dysregulation-centered view of TDP-43 disease mechanisms. TDP-43 however also
binds DNA and has been shown to regulate transcription11,113,114. The role of
transcriptional dysfunction in TDP-43 proteinopathies remains largely unexplored.

Drosophila melanogaster has played an important role in elucidating roles of many
genes in human neurological disease 27,115,116. In Drosophila, expression of human TDP43 leads to neuronal degeneration, shorten lifespan and climbing defects, recapitulating
fundamental disease features and serving as a platform to provide insight into underlying
pathways and therapeutic targets 37,38. To define novel disease mechanisms associated
with TDP-43, we used Drosophila to screen for modifiers of toxicity. Our unbiased
genetic screen uncovered the transcription elongation factor Ell (also known as Su(Tpl))
as a novel and robust modulator. Ell is present in two complexes: little elongation
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complex (LEC) and super elongation complex (SEC) 68,69,72. In Drosophila, LEC,
containing Ell, Eaf, Ice1 and Ice2, regulates the initiation and elongation of Pol IItranscribed small nuclear RNA (snRNA) genes 69,74. SEC is composed of Ell, Eaf, Ear,
Lilli and P-TEFb 66,69. The kinase P-TEFb phosphorylates Pol II, leading to the release of
paused Pol II into productive elongation. The composition and functions of both
complexes are highly conserved in mammals 68,72,74. Neither complex has been
implicated in neurodegenerative disorders.

snRNAs together with a range of proteins form small nuclear ribonucleoproteins
(snRNPs), which are essential components of the splicing machinery of the
spliceosome. In both ALS and FTD patients, splicing changes have been observed by
transcriptome and microarray analyses, implicating aberrant splicing as an important
disease mechanism 84,117. In ALS and human cell disease models with TDP-43
depletion, disruption of several snRNA levels has been reported, both higher 87 and
lower levels 86, but the detailed mechanism and whether these alterations are
functionally important in disease is unclear. In normal physiology, SEC activity has been
shown to be specific to select conditions and genes: developmental genes under
differentiation signals 73, and heat shock genes upon stress 68,72. The critical role of heat
shock genes in neurodegenerative diseases has been revealed by studies on molecular
chaperone and other proteins, which maintain proteostasis 101,102. Among the heat shock
genes, one distinct from others encodes no protein product but rather a long non-coding
RNA (lncRNA), named Heat shock RNA omega (Hsrω). Hsrω is functionally required for
normal development and the heat shock response in Drosophila, and is also involved in
multiple other pathways potentially contributing to cellular homeostasis 106,107. In humans,
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Satellite III repeat RNA (Sat III) is the functional orthologue of Hsrω 108 and its role in
neurodegenerative disease is unknown.

Here, we implicate Ell-associated transcriptional elongation complexes LEC and SEC as
misregulated upon TDP-43 toxicity. We identify key non-coding RNA targets, U12 and
Hsrω, as abnormally activated and functionally contributing to TDP-43-induced
degeneration. Extension of these data to disease tissue and demonstration of the
interaction between TDP-43 and one of the human orthologue of Ell, ELL2, implicates
misregulation of human Ell orthologues as a contributor to TDP-43-associated
pathologies.

Results
TDP-43 toxicity is mitigated by modulation of Ell
Flies expressing human TDP-43 in the eye show retinal degeneration 37,38. We employed
these animals to screen for genes that enhanced or suppressed the degeneration of
TDP-43. In the screen, 2933 fly lines with different genetic modifications were tested.
Among them, 12 fly lines enhanced TDP-43 toxicity and 23 fly lines showed
suppression, indicating a limited number of genes can modify TDP-43 toxicity. From this
screen, we found that knockdown of the gene Ell strongly mitigated TDP-43-induced
deterioration of the external eye and internal retina (Fig. 1a, b and Supplementary Fig.
1a). Furthermore, up-regulation of Ell enhanced TDP-43 toxicity with more severe
external eye and internal retinal degeneration (Fig. 1a, b and Supplementary Fig. 1a).
These data indicated that Ell is a potent dose-dependent modifier of TDP-43, with Ell
knockdown or up-regulation on its own having no effect on eye morphology
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(Supplementary Fig. 1b). A RNAi control line against Luciferase did not mitigate TDP-43mediated eye degeneration (Fig. 1a, b).

Ell protein is a shared component of two transcriptional elongation complexes: LEC and
SEC (Fig. 1c). In order to investigate whether the suppression due to Ell knockdown was
through one or the other of these complexes, we downregulated additional components
of LEC and SEC in the presence of TDP-43. Reduction of SEC components ear and lilli
partially suppressed the external and internal retinal deterioration conferred by TDP-43,
as did reduction of LEC component Ice1 (Fig. 1d, e and Supplementary Fig. 1a). The
rescue effect of any of these components was not as strong upon depletion of the
shared component Ell, suggesting that both LEC and SEC contribute to TDP-43 toxicity.
Depletion of any of the components on their own had no effect on eye integrity
(Supplementary Fig. 1b).

The levels of the TDP-43 protein were assessed by western immunoblot. These data
indicated that enhancement by Ell up-regulation or suppression by lowered levels of Ell
or other components of LEC or SEC was not through modulating the levels of TDP-43
protein (Supplementary Fig. 1c). We further confirmed that the GAL4-UAS expression
system was not impacted by any of these components by examining the levels of a
control protein β-galactosidase (β-gal) (Supplementary Fig. 1d). Additional fly lines,
including a genetic mutation of Ell, and two RNAi lines of Ice1 with proper controls were
tested and showed consistent suppression effect on TDP-43-caused eye degeneration
(Supplementary Fig. 1e).
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To extend these studies to the nervous system generally, we expressed TDP-43 in all
neurons in the adult animal using a conditional drug-inducible driver line. With
expression in the adult fly brain induced by RU486, TDP-43 animals consistently show
an age-associated decline in climbing ability, indicative of neural dysfunction (Fig. 1f,
Supplementary Fig. 1f and 38). Knockdown of Ell, although showing no effect on its own,
restored climbing ability to normal without affecting TDP-43 protein levels (Fig. 1f, g and
Supplementary Fig. 1g). We also assessed the suppression effect of Ell on TDP-43
toxicity in the nervous system by lifespan assays using the drug-inducible neuronal
driver. Knockdown of Ell on its own caused mild but statistically significant extension of
lifespan, and downregulation of Ell caused a mild suppression of TDP-43-shorten
lifespan and a shift of the early stage of the lifespan curve (Supplementary Fig. 1h).
Lifespan assays assessing Ell knockdown effect on TDP-43 toxicity were also tested by
using a ubiquitous drug-inducible driver, showing consistent results that Ell
downregulation has some effect to mitigate TDP-43 toxicity (Supplementary Fig. 1I).
These data indicate that increased activity of both Ell-complexes LEC and SEC may
contribute to TDP-43-mediated degeneration in the nervous system.

LEC snRNA target U12 contributes to TDP-43 toxicity
To determine whether the activity and function of LEC and SEC are promoted by TDP43, we assessed the downstream targets in the fly disease model. Targets of LEC are
Pol II-transcribed snRNAs 69,74. We therefore used Northern blot analysis to assess the
levels of snRNAs U1, U2, U4, U4atac, U5, U7, U11 and U12 in fly heads, with or without
added TDP-43 driven by a ubiquitous drug-inducible driver. TDP-43 expression
significantly increased levels of U1, U4, U7 and U12 (Fig. 2a and Supplementary Fig.
2b). Importantly, knockdown of Ell restored the levels of the elevated snRNAs back to
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normal without affecting TDP-43 expression (Fig. 2a and Supplementary Fig. 2a, b).
These data suggest that misregulation of snRNA components may be a consequence of
disrupted Ell function in the animals and contribute to TDP-43 toxicity.

To test the functional role of the snRNAs in TDP-43-induced degeneration, we
determined whether downregulation of the elevated snRNAs could mitigate toxicity. We
examined fly lines predicted to downregulate various snRNAs (U1, U4, U7, U12). There
was little effect of fly lines directed to U1 and U4 (there are multiple copies of these
snRNAs in the genome making interference challenging), and U7 depletion suppressed
the external eye but did not suppress the internal deterioration. Although we cannot
exclude the potential importance of U1, U4 and U7, we focused on U12. U12 knockdown
partially, but consistently mitigated TDP-43-associated retinal disruption (Fig. 2b, c and
Supplementary Fig. 2c), indicating that misregulation of U12 levels is functionally
important to TDP-43 toxicity. We confirmed that U12 downregulation had no effect on
TDP-43 protein, and that reduction of U12 on its own did not affect the eye
(Supplementary Fig. 2d, e). U12 is a component of the minor spliceosome (U12-type
spliceosome), indicating that targets of the minor spliceosome may be misregulated by
TDP-43.

There are 18 genes containing a U12-type intron in Drosophila 100. Total RNA from fly
heads was prepared for reverse transcription quantitative PCR (RT-qPCR) with qPCR
primer sets spanning the U12-regulated introns to assess the levels of spliced gene
products (Fig. 2d). Among the 18 genes, six (CG16941, CG11839, CG33108, CG11328,
CG15735 and CG3294) were up-regulated with expression of TDP-43, with the other 12
genes not affected (Fig. 2e; Supplementary Fig. 2f, g), indicating increased U12 levels
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leads to elevation of specific minor spliceosome targets. Knockdown of Ell corrected the
levels back to normal (Fig. 2e; Supplementary Fig. 2g), consistent with the ability of Ell
downregulation to normalize the levels of U12 and protect from TDP-43 toxicity. To
further determine whether the elevation resulted from transcription or splicing, we
assessed the levels of the unspliced transcripts. The unspliced products of 3 genes,
CG33108, CG11328 and CG3294 were also increased upon TDP-43 expression,
indicating a change in total transcript levels (Supplementary Fig. 2g). The unspliced RNA
levels of the 3 genes CG15735, CG16941 and CG11839 were not altered significantly
by the presence of TDP-43, indicating that the splicing of these U12-regulated introns
was increased (Fig. 2e). These data indicate that the U12-type spliceosome is
abnormally activated in the fly disease model to cause disrupted regulation of selected
downstream targets.

TDP-43 and Lilli co-localize at the Hsrω lncRNA locus
Ell is also a component of SEC and SEC activates transcriptional elongation, which is
critical for genes involved in developmental signaling pathways and the stress response
68,72,73

. The SEC scaffold protein Lilli binds to and regulates specific targets on the

chromosomes in Drosophila and human cells 68,72,73. Recently, genome-wide chromatin
immunoprecipitation (ChIP-seq) shows that Drosophila TDP-43, TBPH, associates with
chromatin 114. We therefore considered that TDP-43 may co-localize to the same genes
as Lilli. To explore this, we expressed TDP-43 tagged with YFP in Drosophila salivary
gland and assessed Lilli and TDP-43 localization on the polytene chromosomes by
immunostaining. Under ambient temperature, we observed that TDP-43 binds to
polytene chromosomes with specificity (Fig. 3a). TDP-43 and Lilli each localized to ~115
sites (Fig. 3a). Most of these were euchromatin regions where active transcription
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usually occurs. Detailed analysis of the co-localization pattern indicated that TDP-43 and
Lilli consistently overlapped at 16 sites across chromosomes X, 2R, 3R and 3L (Fig. 3a
and Supplementary Table 1). Although it is difficult to precisely identify the genes with
co-localization of TDP-43 and Lilli due to the resolution of polytene bands, these data
indicate partial overlap of TDP-43 and SEC targets in normal conditions; these genes
may be important in toxicity.

Upon heat stress, SEC is recruited to major heat shock loci on the polytene
chromosomes and, further, has been shown to regulate the expression of a major heat
shock protein Hsp70 68. Dysfunction of the heat shock response, which functions to
maintain proteostasis, is associated with TDP-43 toxicity 103-105. We therefore probed
whether TDP-43 co-localized to these targets of SEC. As noted 68, with heat shock Lilli
localizes to the major molecular chaperones at polytene chromosome sites 63B, 67B,
95D, 87A and 87C and a unique heat shock locus, 93D that encodes the lncRNA Hsrω
(Fig. 3b). When we examined co-localization with TDP-43, we noted some colocalization at 63B (encoding Hsp83) and 67B (encoding small heat shock genes)
(Supplementary Table 2). Moreover, we observed robust and consistent co-localization
at 93D in all polytene chromosome spreads examined (Fig. 3b and Supplementary Table
2); this was a site at which TDP-43 and Lilli also co-localized without added stress
(Supplementary Table 1), suggesting that this stress-induced lncRNA may be a common
target of TDP-43 and Lilli. We also assessed the co-localization of TDP-43 and Ell.
Consistent with the results of immunostaining with Lilli, Ell also co-localized with TDP-43
at the 93D locus encoding Hsrω (Supplementary Fig. 3a). Precision nuclear run-on
sequencing (PRO-seq) has shown that pol II is paused on Hsrω 118, and chromatin
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staining shows that SEC components, Ell and Lilli, co-localize with elongating Pol II at
the 93D locus after heat stress 68, both indicating that Hsrω is a target of SEC.

Given the limited resolution of polytene chromosome staining, we analyzed the
published ChIP-seq data for TBPH 114 and Lilli 69 to better define genes bound by both
factors. This analysis showed that TBPH binds to 383 genes and Lilli binds to 4162
genes (Fig. 3c and Supplementary Data 1). Among them, 328 genes were bound by
both factors, which comprises ~86% of the genes bound by TBPH and ~8% of the genes
bound by Lilli (Fig. 3c). Consistent with the polytene data, Hsrω is a target of both TBPH
and Lilli (Fig. 3d). We therefore considered that Hsrω might be a target of SEC that
becomes misregulated by TDP-43.

Hsrω functionally modulates TDP-43 toxicity
The 93D locus encodes nuclear and cytoplasmic lncRNAs referred to as Hsrω-n and
Hsrω-c, respectively, both of which are induced by stress. Upon heat stress, Hsrω-n
transcripts are up-regulated at the 93D site 106, with a balanced level of Hsrω being
critical for the survival and recovery of flies following heat stress 107. Given the striking
co-localization of TDP-43 and Lilli at the Hsrω locus, we considered that dysregulation of
Hsrω may occur with TDP-43. RNA from fly heads in the presence or absence of added
TDP-43 expression was extracted for RT-qPCR and the levels of total Hsrω (Hsrω-c and
Hsrω-n), and Hsrω-n were determined. Total Hsrω and Hsrω-n were increased ~2-fold
upon TDP-43 expression (Fig. 4a). Importantly, this misregulation was reduced toward
normal levels by Ell knockdown (Fig. 4a). These data indicate that Hsrω may be a
functional target of SEC activity that contributes to TDP-43-associated degeneration.
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To assess whether misregulation of Hsrω is functionally important to TDP-43 toxicity, we
reduced the levels of Hsrω in animals expressing TDP-43. Reduction of Hsrω by placing
animals expressing TDP-43 in trans to an Hsrω null mutation partially mitigated TDP-43associated external and internal retinal deterioration (Fig. 4b, c). This was not associated
with changed levels of TDP-43 protein, and loss of one copy of Hsrω on its own had no
effect (Supplementary Fig. 4a, b). We also confirm the suppression effect of Hsrω
downregulation on TDP-43-mediated eye degeneration by a RNAi line with proper
controls (Supplementary Fig. 4c). The effect of lacking one copy of Hsr⍵ on climbing
defect caused by TDP-43 was unable to be determined because reduction of Hsr⍵ on its
own caused a decrease in climbing ability (data not shown). Taken together, these
findings on the co-localization of TDP-43 and Lilli at the Hsrω gene locus, on elevated
levels of Hsrω RNAs in TDP-43-expressing animals, and on functional mitigation of
TDP-43-induced degeneration by modulation of Hsrω levels suggest that the stressinduced lncRNA Hsrω is a functional target of TDP-43 that contributes to TDP-43mediated degeneration.

Sat III is upregulated in a cellular model and in patient tissue
These data on Hsrω raised the possibility that the functional orthologue of Hsrω in
humans, the stress-induced Satellite III repeat RNA (Sat III) 108, may become
misregulated in disease and contribute to toxicity. Although not sharing precise
sequence similarity, Hsrω and Sat III transcripts share functional features and regulatory
mechanisms: they are repeats and non-coding in nature; they are induced and
accumulate at the site of synthesis upon stress, and associate with heterogeneous
nuclear ribonucleoproteins (hnRNPs) and other RNA-processing factors; they are both
Pol II-dependent transcripts 106,108,109. Moreover, although Sat III is essential for cell
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survival after heat shock, upregulation of Sat III promotes cell death and acute
senescence in various cell models 119,120. We therefore investigated whether Sat III
transcripts became misregulated by TDP-43.

To assess Sat III levels in mammalian cells, we used human embryonic kidney 293
(HEK293) cells expressing doxycycline-induced GFP-tagged TDP-43 (GFP-TDP-43) or
GFP alone. RNA was prepared following 6d of induction, and the levels of Sat III
transcripts were examined by RT-qPCR. We compared Sat III levels in cells expressing
GFP-TDP-43 to control cells expressing GFP. TDP-43 expression led to a ~4-fold
increase in the steady state level of Sat III (Fig. 5a). The Sat III primers were validated
by heat shock induction of Sat III followed by RT-qPCR analysis (Supplementary Fig.
5a). Thus, the human counterpart of Hsrω became misregulated upon aberrant TDP-43
expression in cells.

These findings raised the possibility that Sat III may become dysregulated in human
disease. To address this, we used RNA prepared from frontal cortex of 13 FTD patients
(six sporadic or with unknown family history and seven patients with a family history of
FTD and/or a disease-associated mutation) and six clinically normal controls (Fig. 5b).
All of the FTD patients had TDP-43 pathology (FTLD-TDP) 121,122. In accordance with our
studies in the fly and human cells, the results showed that the levels of Sat III transcripts
were significantly higher in the frontal cortex of FTD patients compared to controls (Fig.
5b). Case numbers and details are indicated in Table 1. Taken together with the
functional data from the fly, misregulation of the stress-induced lncRNA Sat III may be a
contributor to TDP-43-associated disease.
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TDP-43 and ELL2 proteins interact
To further dissect the relationship between Ell and TDP-43 and define additional
mechanisms by which Ell may contribute to TDP-43-mediated neurodegeneration, we
assessed whether Ell levels were upregulated in disease models; upregulation of Ell
could lead to increase levels of downstream targets and in this manner contribute to
TDP-43-mediated neurodegeneration. RNA levels of fly Ell were examined by RT-qPCR
using RNA extracted from fly heads in the presence or absence of added TDP-43.
These data showed that Ell is elevated ~50% upon TDP-43 expression (Fig. 6a). We
next examined human ELL proteins in the HEK293 cell model. In mammals, there are
three proteins in the ELL family: ELL, ELL2 and ELL3 66, with ELL3 being the most
distinct based on sequence (~50% identity) and enriched in testis 47. All three ELL
proteins can be pulled down with factors in LEC and SEC 68,69. We examined the RNA
levels of ELL and ELL2 in cells expressing GFP-TDP-43 or GFP control by RT-qPCR.
The results are consistent with the fly data, showing that TDP-43 expression led to a
50% increase of ELL and ELL2 levels (Fig. 6b). However, when we assessed protein
levels by western immunoblot, the results indicate that the levels of ELL and ELL2 were
not changed (Supplementary Fig. 6a). We also examined ELL and ELL2 by RT-qPCR
using RNA prepared from frontal cortex of the 13 FTD patients with TDP-43 pathology;
expression levels of ELL and ELL2 were not changed significantly compared to controls
(Supplementary Fig. 6a). These results, together with the data showing that upregulation
of Ell on its own does not cause eye degeneration (Fig. 1a and Supplementary Fig. 1b),
indicate that mechanisms beyond simply a global increase in levels of Ell may be
involved in TDP-43-associated toxicity.
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The polytene chromosome immunostaining showed that TDP-43 co-localized with Ell
and Lilli at the 93D locus (Fig. 3a and Supplementary Fig. 3a), indicating that
interactions between the proteins might occur. We thus assessed whether endogenous
TDP-43 interacts with ELL or ELL2 in nuclear extracts of HEK293 cells using coimmunoprecipitation (co-IP). TDP-43 was immunoprecipitated by an anti-TDP-43
antibody (Fig. 6c), and western blots then probed for presence of coimmunoprecipitating ELL or ELL2. ELL was not detected; however, ELL2 was coimmunoprecipitated together with TDP-43 (Fig. 6c). This was specific because ELL2 was
not co-immunoprecipitated with IgG control. These data indicate that TDP-43 interacts
with ELL2, suggesting that this interaction may contribute to dysfunction of ELLassociated complexes upon aberrant TDP-43 function.

Discussion
Misregulation of several transcriptional elongation factors has been reported in diseases,
including viral pathogenesis and cancer 79,123, yet these factors have not been implicated
in neurodegenerative disorders. Here we report that Ell and Ell-containing transcriptional
elongation complexes LEC and SEC are novel modifiers of TDP-43 toxicity. The levels
of several LEC target snRNAs including U12 are upregulated by TDP-43 proteinopathy.
Our data suggest that the U12-type spliceosome is abnormally activated and contributes
to toxicity. Through chromatin immunostaining, we identify a key target of SEC, a stressinduced lncRNA Hsrω, as aberrantly elevated and functionally important to TDP-43mediated degeneration. In addition, we show that the levels of the human orthologue of
Hsrω, Sat III, is increased in a human cell model and in FTLD-TDP frontal cortex tissue,
indicating that Sat III dysfunction may contribute to TDP-43-associated disease. Finally,
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we demonstrate TDP-43 interacts with the one of the human orthologues of Ell, ELL2,
indicating that the aberrant elevation of LEC and SEC activity in disease may be
promoted through the interactions between TDP-43 and ELL2 (Fig. 7). These findings
highlight the critical roles of LEC and SEC in TDP-43-mediated pathologies, and
highlight that approaches to normalize the activity of human orthologues of the shared
component Ell may be of therapeutic benefit.

Our data suggest a model whereby SEC and LEC contribute to TDP-43-mediated
degeneration in parallel (Fig. 7). We find that that depletion of the shared component Ell
led to nearly full suppression of TDP-43-mediated eye degeneration, whereas, by
contrast, downregulation of LEC- and SEC-specific components or downstream targets
U12 and Hsrω showed only partial suppression, despite the downregulation effect for the
genes being robust. In our study, we identified important targets that are functionally
involved in TDP-43-mediated degeneration, but we do not exclude the possibility that
there may be other targets regulated by LEC and SEC that are important in the disease.
Furthermore, we show that up-regulation of the shared component Ell enhances TDP-43
degeneration, and the abnormally elevated levels of LEC and SEC targets caused by
TDP-43 toxicity can be rescued by Ell depletion. Our study demonstrates that TDP-43mediated degeneration can be alleviated by decreasing the activities of LEC and SEC,
which is predicted to lead to reduction of elongating Pol II on downstream key targets
and thus lower their levels.

As an RNA binding protein, TDP-43 has been demonstrated to regulate targets through
direct binding 13,111,124. Our studies propose another layer of regulation: we hypothesize
that TDP-43 affects transcription through misregulation of LEC and SEC activities,
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contributing to degeneration. Furthermore, the data showing that TDP-43 interacts with
ELL2 (Fig. 6c) suggests a mechanism which TDP-43 may promote the activities of LEC
and SEC at target genes, through interactions of the TDP-43 with ELL2 (Fig. 7).

Our data highlight elements of specificity in TDP-43-associated toxicity. First, we show
that only selected targets of LEC and SEC are elevated in expression in the fly upon
TDP-43 expression. The selectivity of targets can be defined by accessory factors
associated with the LEC and SEC: in human cells, a mediator subunit MED26 has been
shown to interact through EAF1 and EAF2 and promote the expression of select target
genes, including a subset of snRNAs and Hsp70 125,126. Other factors like PAF1 and
integrator, interacting with SEC 127,128, might also contribute to target specificity.

Our data showing that TDP-43 binds to Drosophila polytene chromosomes with
selectivity (Fig. 3a, b), and that TDP-43 interacts with ELL2 (Fig. 6c), suggest specificity
could also be defined by TDP-43. In HIV infection and leukemia, the sequence specific
DNA binding activators, HIV-1 Tat protein and MLL respectively, direct SEC to specific
target genes for their abnormal expression 68,70,71. Thus, it is possible that TDP-43 serves
as a sequence specific DNA or RNA binding factor and therefore defines target
specificity in associated diseases. A second layer of specificity is that, upon increased
U12 snRNA levels, among 18 target genes with a U12-type intron, only 6 become
misregulated with TDP-43. The detailed mechanisms by which specificity is established
is an intriguing question that remains to be addressed.

In models of the motor neuron disease spinal muscular atrophy (SMA), expression levels
and splicing of several genes containing a U12-type intron are decreased 100. Our data
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show that the activity of the minor spliceosome is affected in an opposite direction in
TDP-43 expressing animals, highlighting the importance of a balanced level of the minor
spliceosome in maintaining normal motor neuron function. Products of 6 minor
spliceosome-regulated genes were increased with TDP-43, with 3 genes potentially
regulated through transcription and 3 genes likely through misregulation of splicing (see
Fig. 2e and Supplementary Fig. 2f, g); among these, expression of 3 genes (CG33108,
CG16941 and CG11839) are decreased in a fly model of SMA 100. This finding indicates
misregulation of common target genes in different motor neuron disease models.
Misregulation of orthologues of some of these genes have been reported in mammalian
models of ALS and FTD or in human patients: the splicing of a U12-type intron in
C19orf54, the human orthologue of CG33108, is affected in an ALS transgenic mouse
model expressing human FUS, which is encoded by a gene that, when mutated, can
cause ALS and rare cases of FTD 129. Another gene, SF3A1, the human orthologue of
CG16941, shows altered poly-A usage in ALS patients bearing the C9orf72 GGGGCC
hexanucleotide repeat expansion 84, the most common known genetic cause of ALS and
FTD 84,130,131. SF3A1 is also implicated as a novel risk factor in FTD by gene coexpression network analysis 132. Our findings, together with others, indicate that these
genes may be critical in TDP-43-associated disorders.

We report that the stress-induced repetitive RNA Sat III is increased in TDP-43associated disease, which suggest that the elevation may contribute to neuronal loss
and degeneration. We used both HEK293 cell disease model and human patient
samples to verify findings in different systems. Stress genes maintain proteostasis and
promote cell survival. However, the stress response can be diverse depending on the
circumstances 133,134. The induction of Sat III by TDP-43 is significant although mild (~442

fold; see Fig.5), leading us to consider that expression of TDP-43 may be akin to a
chronic stress that triggers distinct pathways from those induced by an acute heat shock
response (whereby Sat III is induced many thousand-fold (see Supplementary Fig. 4)).
In support of this idea, although Sat III is required for cell survival after heat shock,
forced expression of Sat III triggers cell death and rapid cellular senescence 119,120.
Elevated Sat III transcripts have been noted in senescent cells and fibroblasts from
patients with the premature aging disease Hutchinson-Gilford progeria syndrome
(HPGS) 135,136. Furthermore, normalization of elevated Sat III largely rescues the mitotic
dysregulation and senescence phenotype of SIRT6-depleted cells 120, indicating that
elevated Sat III contributes to age-related cellular abnormalities. These studies support
our findings and model that elevated Sat III is detrimental and may contribute to TDP-43associated neuronal dysfunction. The influence of ELL proteins on the induced Sat III
levels by TDP-43 is an interesting question that remains to be further investigated.

Given our data in Drosophila, the shared component Ell, whose depletion rescued the
elevated levels of LEC and SEC targets, may be an effective therapeutic target.
Importantly, our data also showed that knockdown of Ell on its own did not cause
deleterious effects like degeneration or compromised mobility, further supporting that Ell
may be a promising therapeutic candidate (see Supplementary Fig. 1b, f). Domain
analysis of human orthologues of Ell, ELL and ELL2, identified the N-terminal 150 amino
acids as critical for elongation function 48,137. Given that the ELL family is also reported to
display additional activities, such as serving as an E3 ubiquitin ligase for c-Myc
degradation 138 and inhibiting P53 function 138, a strategy to apply molecules targeting
domains specific for elongation activity, or even targeting the interaction between ELL
proteins and the assembly components of LEC and SEC, ICE1 and AFF4 (human
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orthologue of Lilli), respectively, may be promising. Recent research resolving the
structure of AFF4 and ELL2 binding interface reveal a cavity that is a potential binding
site for small molecules to interrupt SEC activity 139.

The therapeutic potential of ELL family proteins may not be limited to TDP-43-associated
toxicity. Our findings indicate that knockdown of Ell protects against not only TDP-43 but
also GGGGCC hexanucleotide repeat toxicity (Supplementary Fig. 9), which is also a
major disease locus for ALS and FTD. These data suggest that shared targets of these
two toxic insults and of ELL family proteins might be central to degeneration associated
with these mechanisms.

Methods
Drosophila melanogaster
Flies were raised at 25°C. Transgenic flies with TDP-43-YFP and recombinant fly lines
gmr>TDP-43 and elavGS>TDP-43 are described 37,38. The recombinant fly line
daGS>TDP-43 was generated with the fly line daughterless-GeneSwitch (dsGS), a
generous gift from Dr. Veronique Monnier 140. Ice1 RNAi fly line was generated with two
constructs (SH09112.N and SH09113.N) provided by DRSC/TRiP center. Fly lines used
are listed in Supplementary Table 3.

Drosophila external eye and internal eye imaging
Adult female flies (1-2d) were used. For external eyes, flies were anesthetized with ether
and imaged. For retinal tissue imaging, fly heads were embedded in paraffin blocks and
sectioned for images of endogenous autofluorescence. Images of retina sections were
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analyzed by ImageJ to measure the thickness of retina tissue in the middle for
quantification.

RU486 induction in adult fly
Adult male flies (0-1d) were collected and aged in vials containing fly media added with
or without RU486 as indicated (4 mg/ml or 8 mg/ml, 100 μl) to induce gene and RNAi
expression at 25°C for indicated days. 100% ethanol (EtOH) was used as vehicle.

Adult fly climbing assay
Adult male flies were collected for RU486 induction. Assays were conducted between
10-11 am. Plastic vials (height=9.5 cm) were used for the assay. Flies were transferred
into plastic vials at the density of 25 flies per vial 20 min before the assay. For the assay,
flies were tapped to the bottom of the vial, and the number of flies climbing above 5.5 cm
was counted after 15 sec (3 repeats). For each trial, a cohort of 100 flies was assessed
for each genotype over 21 days.

Fly lifespan assay
Male flies were collected 0-1 days after eclosion and transferred into vials containing fly
media with or without RU486 at a density of 20 flies per vial. Flies were transferred to
fresh media every other day and the numbers of dead flies were scored. For each group,
200 flies were used in each experiment.

Western blotting
Adult male fly heads (1-2d unless otherwise noted) were homogenized in Laemmli
sample buffer (Biorad) with βME, boiled and centrifuged to remove debris. NuPAGE 445

12% Bis-Tris gel (Thermo Fisher) was used to run the samples. Proteins were
transferred to nitrocellulose membrane by the iBlot blotting system (ThermoFisher). For
human cell samples, cells (~9.6*105) were lysed in RIPA buffer (Cell signaling; #9806)
supplemented with PMSF and proteinase inhibitor protease inhibitor cocktail (Roche;
#1183670001). Extracts were sonicated for total 6 min using using QSonica (Newtown,
CT) water bath sonicator (amplitude = 100, 30 s on, 30 s off). After centrifugation the
concentrations of the protein samples were measured by Pierce BCA kit (Thermo;
#23225). Same amount of proteins was prepared for each sample with NuPAGE LDS
sample buffer (Invitrogen; #NP0007), boiled at 95°C, 5min and run on NuPAGE 4-12%
Bis-Tris gel (Thermo Fisher). Proteins were transferred to PVDF membrane by the XCell
SureLock system (Invitrogen). Primary antibodies used were anti-TDP-43 rabbit
polyclonal antibody (1:5000; Proteintech; #10782-2-AP), anti-β-gal mouse monoclonal
antibody (1:2000; Promega; #Z378A), anti-α-tubulin rabbit polyclonal antibody
conjugated with HRP (1:1000; Cell signaling; #9099), anti-ELL rabbit polyclonal antibody
(1:1000; Proteintech; #51044-1-AP), anti-ELL2 rabbit polyclonal antibody (1:1000;
Bethyl; #A302-505A), anti-ELL2 mouse monoclonal for co-IP immunoblots (1:1000;
Santa Cruz; #sc-515276) and anti-GAPDH mouse monoclonal (1: 10,000; AbD Seotec;
#4699-9555). The secondary antibodies used were goat anti-rabbit IgG-HRP (1:5000;
Milipore, #AP307P) and goat anti-mouse (1:5000; Jackson ImmunoResearch; #115-035146). All blocking and antibody incubations were done in 5% milk in PBS overnight (O/N)
at 4°C for primary and 1 hr at room temperature (RT) for secondary. Signals were
developed by ECL plus (ThermoFisher) or ECL prime (GE healthcare) western blotting
reagents. The images were scanned by Fujifilm LAS-3000 imager (Fujifilm) or
Amersham Imager 600 (GE healthcare), and quantification was performed using
ImageJ. The uncropped blots in the main figures are provided in Supplementary Fig. 7.
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Small RNA Northern blotting
Total RNAs were extracted from fly heads using Trizol reagent (ThermoFisher;
#15596026), following the manufacturer’s protocol. RNA quality was checked by gel, and
0.6-3 μg of total RNA was loaded in 15% TBE-urea gel (ThermoFisher; #EC68852BOX).
RNAs were then transferred onto nylon membrane (GE HealthCare; #RPN303B) and
cross-linked by UV. The membrane was then prehybridized by UltraHyb Oligo
Hybridization Buffer (ThermoFisher; #AM8663) and then hybridized with P32-labeled
probes overnight at 50°C. To make the probes, DNA oligos were annealed to obtain the
template for RNA probes, which were synthesized by in vitro transcription using
MAXIscript T7 kit (ThermoFisher; #AM1312), supplemented with P32-a-UTP. Signals
were detected by GE Amersham Typhoon 9410 Imager and analyzed by ImageJ for
quantification. Probes used are listed in Supplementary Table 4. The same blots were
used to probe 2 different snRNAs: either U1 and U11; U2 and U5; U4 and U7 or U4atac
and U12. The uncropped scans of the blots are shown in Supplementary Fig. 8.

Drosophila polytene immunohistochemistry
To obtain larvae in the approximately same developmental stage, fly food was mixed
with 0.05% bromophenol blue, and light blue wandering larvae were selected for
experiments. Salivary glands were dissected in PBST (0.05% Tween20) and fixed with
45% acetic acid and 2% paraformaldehyde for 1 min and transferred into a drop of 45%
acetic acid on a sigma-coated coverslip. The salivary glands were then squashed onto
Fisherbrand Superfrost Plus Microscope slides (Fisher Scientific), and liquid nitrogen
was used to freeze the slides. Slides were blocked at RT for 1 hr, and incubated with
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anti-GFP mouse monoclonal antibody (1:500; Takara; #632380), anti-Lilli rabbit
polyclonal antibody (1:500; a generous gift from Dr. Ali Shilatifard) and anti-Ell rabbit
polyclonal antibody (1:500; a generous gift from Dr. Ali Shilatifard) overnight at 4°C. The
secondary antibodies were goat anti-mouse IgG Alexa Fluor488 (1:500; ThermoFisher;
#A-11001) and goat anti-rabbit IgG Alexa Fluor488 (1:500; ThermoFisher; #A-11037). All
blocking and antibody incubations were done in 3% BSA in TBST (0.05% Tween20).
DAPI (ThermoFisher; #D3571) was used for nucleic acid staining. The spreads were
mounted using Dako fluorescence mounting medium (Dako; #S3023) and imaged on a
Leica DM6000 CS confocal microscope. For heat shock treatment, larvae were
incubated for 5 min at 37°C.

Reverse transcription quantitative PCR
Total RNA from larvae, whole fly, fly heads, human cultured cells or human tissue was
extracted using Trizol reagent (ThermoFisher; #15596026), following the manufacturer’s
protocol. DNA was removed by Turbo DNA-free kit (ThermoFisher; #AM1907) for fly
samples, RNeasy micro kit (QIAGEN; #74004) for human cultured cells or DNase I
(ThermoFisher; #18068015) for human tissue samples. RNA quality was checked by gel
or Agilent 2100 Bioanalyzer system (Agilent). Reverse transcription was performed with
random hexamers using High-Capacity cDNA Reverse Transcription kit (ThermoFisher;
#4368814) for samples from fly tissues and human cultured cells or SuperScript III
Reverse Transcriptase (ThermoFisher; #18080093) for human tissue samples. Fast
SYBR green master mix (ThermoFisher; #4385614) was used for qPCR performed by
ViiA 7 Real-Time PCR system (ThermoFisher). Primers used for qPCR are listed in
Supplementary Table 5, 6. Sequences of primers for CG6323, CG8408, CG16941,
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CG11839, CG7892, CG13431, CG33108, CG16941 U12int and CG11839 U12int are as
previously described 100.

ChIP-Seq data analysis
Raw fastq data from GSM345570 and GSM345568 (input control and Lilli ChIP-seq,
respectively, were used to call Lilli peaks 69. Raw fastq data from GSM2224492 and
GSM2224493 (input control replicates), GSM2224501 GSM2224502, GSM2224503, and
GSM2224504 (TBPH ChIP-seq) were used to call narrow TBPH peaks 114. Narrow
peaks were called using the mosaics R package 141. Read trimming, alignment and peak
calling steps were performed in R using a published pipeline 142. Software packages
used were mosaics v2.12.0, Rbowtie v1.14.0, dada2 v1.2.2, quasR v 1.14.0,
TxDb.Dmelanogaster.UCSC.dm6.ensGene v3.3.0, GenomicRanges v1.26.4,
GenomicFeatures v1.26.4, BSgenome v1.42.0, biomaRt v2.30.0, AnnotationDbi v1.36.2,
deeptools v3.1.0, python v2.7.10, Integrative Genomics Viewer v2.3.93, and R v3.3.2.
Mosaics peaks were called using the default parameters, with the exceptions of analysis
type IO, false discovery rate (FDR)=0.05. Only regions with a called mosaics narrow

peak in all biological replicates, when compared to both controls, were counted as a
peak. If these peaks lay within 250 bp of a transcription start site, the corresponding
gene was considered to have a peak.

Human cell culture
The doxycycline-inducible (TetON) HEK293 cell lines, TetOn-GFP (clone#9.3) and
TetOn-GFP-TDP-43 (clone#12.5) generated using a subclone of HEK293 cells (QBI293) are generous gifts from Dr. Virginia Lee’s laboratory. Cells were grown in
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Dulbecco’s modified Eagle’s medium (DMEM) with L-glutamine, glucose and sodium
pyruvate (Corning; #MT10013CV), supplemented with 10% Tet system approved FBS,
1% penicillin/streptomycin. Media was further added 400 μg/ml G418 and 1 μg/ml
puromycin. Cells were cultured at 37°C and 5% CO2 and routinely sub-cultured at 1:10
ratio every 7 days. To induce expression, 1000 ng/ml doxycycline was added for 6 d. For
heat shock treatment, cells were subjected to heat stress at 46°C followed by 6 hr
recovery. Cells were checked for appropriate GFP-tagged protein expression.

Human frontal cortical tissue
Human postmortem brain samples were obtained from the University of Pennsylvania
Center for Neurodegenerative Disease Brain Bank. All relevant ethical regulations were
compiled, and informed consent from next of kin was obtained for all cases. These
comprised samples from clinically normal individuals (n = 6), as well as individuals with
FTLD-TDP (n = 13). The region sampled was midfrontal cortex (BA9), and all disease
cases were previously reported and confirmed to have TDP-43 pathology 121,122. DNA
was extracted from all cases and screened for mutations in the two most common genes
associated with FTLD-TDP, GRN and C9orf72. Briefly, the coding regions of GRN were
bi-directionally sequenced by Sanger sequencing using flanking primers to each exon as
previously described 143. Sequence analysis was done with Mutation Surveyor
(SoftGenetics, State College, PA). Analysis for hexanucleotide repeat expansions in
C9orf72 was performed using a modified repeat-primed PCR method 144. Analysis of the
valosin containing protein gene (VCP) analysis was performed by targeted Sanger
sequencing of the relevant exon in a case with known family history of a VCP mutation
145

.
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Co-IP
Endogenous Co-IP was performed by using the nuclear extract of HEK293 TetOn-GFP
(clone#9.3) cells without doxycycline induction. Cells (~2.6*107) were resuspended in
hypotonic solution (20 mM Tris-HCl (pH 7.5), 20 mM NaCl, 5 mM MgCl2) supplemented
with protease inhibitor cocktail (Roche; #1183670001) and homogenized by Dounce
homogenizer. After centrifugation (3,000 g, 4°C, 15 min), the pellet containing nucleus
was resuspended in Pierce IP lysis buffer (Thermo; #87787) supplemented with
protease inhibitor cocktail (Roche; #1183670001). After centrifugation (15,000 g, 4°C,
10 min), input sample was saved, and the rest of the lysate were divided to incubate
at 4°C, overnight with Dynabeads Protein G (Invitrogen; #1004D) prepared with 5 µg
of anti-TDP-43 mouse monoclonal antibody- mAb 5028146 (a generous gift from Dr.
Virginia Lee’s lab) or same amount of mouse IgG control (Santa Cruz; #sc-2025). The
next day, the beads were washed with lysis buffer 3 times, with the 3 rd time rotating
the tubes for 5 min in 4°C. Elute the proteins by NuPAGE LDS sample buffer
(Invitrogen; #NP0007) by boiling at 95°C, 5min. The following western blotting were
performed as described above. Experiments were repeated to confirm the results.

Statistical analysis
Graphs are represented as mean±standard deviation (SD). The statistics used are
indicated in each figure legend. Comparison between two groups were calculated using
the two-tailed unpaired Student’s t test. If data sets show significant variance according
to variance F-test analysis, two-tailed unpaired Student’s t test with Welch’s correction
was used as indicated in the figure legend. Shapiro-Wilk normality test was used for
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testing normal distribution for all data sets except data sets normalized to 1. If the data
are not normally distributed, two-tailed unpaired Mann-Whitney Test (nonparametric test)
was used as indicated in the figure legend. The differences among three groups were
calculated using ANOVA followed by Tukey’s multiple comparison test. Brown-Forsythe
test and Shapiro-Wilk normality test were used to test variance differences and normality
respectively for data analyzed by One-way ANOVA. Differences with P-values <0.05
were considered statistically significant. The number of sample size and biological
replicates is indicated in the methods section or figure legend. No statistical method was
used to predetermine sample sizes. No sample was excluded from the analysis. No
method of randomization was used. The investigators were not blinded to allocation
during experiments.

Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request.

Code availability
The code used for analysis is available upon request.
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Figures

Figure 1. Components of LEC and SEC modulate TDP-43 toxicity
(a) TDP-43 expression causes eye degeneration that is suppressed by Ell RNAi and
enhanced by Ell upregulation. Scale bars: external eye images (top), 100 μm; internal
retinal section (bottom), 5 μm. Genotypes: Control is gmr-GAL4(YH3)/+. gmr>TDP-43 is
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UAS-TDP-43/+; gmr-GAL4(YH3)/+. gmr>TDP-43+Control RNAi is UAS-TDP-43/+; gmrGAL4(YH3)/UAS-Control.RNAiJF01355. gmr>TDP-43+Ell RNAi is UAS-TDP-43/+; gmrGAL4(YH3)/UAS-Ell.RNAiHMS00277. gmr>TDP-43+Ell is UAS-TDP-43/+; gmrGAL4(YH3)/UAS-EllP{EP}G4098.
(b) Quantification of retina thickness related to Fig. 1a. Three flies of each genotypes
were measured (n=3). Bars represent mean (SD). (**) P <0.01, (****) P<0.0001(Twotailed unpaired Student’s t test). Genotypes are the same as indicated in Fig. 1a. (A.U.)
arbitrary units.
(c) Schematic of LEC and SEC.
(d) Downregulation of SEC components (ear and lilli), or LEC component (Ice1)
suppresses TDP-43 toxicity. Scale bars: external eye (top), 100 μm; internal retina
section (bottom), 5 μm. Genotypes: gmr>TDP-43 is UAS-TDP-43/+; gmr-GAL4(YH3)/+.
gmr>TDP-43+ear RNAi is UAS-TDP-43/+; gmr-GAL4(YH3)/UAS-ear.RNAiHMS00107.
gmr>TDP-43+lilli+/- is UAS-TDP-43/lilli17-2; gmr-GAL4(YH3)/+. gmr>TDP-43+Ice1 RNAi
is UAS-TDP-43/UAS-Ice1.RNAi (SH09112.N from DRSC/TRiP); gmr-GAL4(YH3)/+.
(e) Quantification of retina thickness related to Fig 1d. Three flies of each genotypes
were measured (n=3). Bars represent mean (SD). (**) P <0.01 (Two-tailed unpaired
Student’s t test). Genotypes are the same as indicated in Fig. 1d. (A.U.) arbitrary units.
(f) TDP-43 expression in the adult neurons by elavGS causes climbing defects.
Knockdown of Ell restores climbing ability. RU486 (8 mg/ml) was used to induce the
expression of TDP-43 and Ell RNAi. EtOH was used as vehicle. Total of 100 flies were
measured 3 times for each genotype at different time points. Bars represent mean (SD).
(***) P <0.001, (****) P<0.0001 (Two-way ANOVA followed by Tukey’s multiple
comparison test). Significant differences are only indicated within the same time point.
Genotypes: elavGS>TDP-43 is elavGS-GAL4, UAS-TDP-43/+. elavGS>TDP-43+Ell
RNAi is elavGS-GAL4, UAS-TDP-43/UAS-Ell.RNAi HMS00277.
(g) TDP-43 protein levels in heads from 7, 14 and 21d flies are not altered by Ell RNAi.
n=3 biological replicates. Tubulin was used as internal control. Bars represent mean
(SD). (NS) not significant (Two-tailed unpaired Student t test with Welch’s correction).
Genotypes and RU486 treatment are as in Fig. 1f.
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Figure 2. U12 snRNA is upregulated and a functional target of TDP-43
(a) Northern blot analysis shows that the level of snRNAs U1, U4, U7 and U12 are
upregulated by TDP-43 expression driven by a ubiquitous drug-inducible promoter,
daGS, in heads. Ell RNAi corrects the increased levels of snRNAs. RU486 (4 mg/ml)
was used to induce the expression of TDP-43 and Ell RNAi for 8d. 2S rRNA was the
loading control. n=3 biological replicates. Bars represent mean (SD). (*) P <0.05, (**) P
<0.01, (***) P <0.001, (****) P<0.0001 (One-way ANOVA followed by Tukey’s multiple
comparison test). Genotypes: daGS>TDP-43 is daGS-GAL4/+; UAS-TDP-43/+.
daGS>TDP-43+Ell RNAi is daGS-GAL4/+; UAS-TDP-43/UAS-Ell.RNAiHMS00277.
(b) Knockdown of U12 suppresses eye degeneration caused by TDP-43 toxicity. Scale
bars: external eye (top), 100 μm; internal retina (bottom), 5 μm. Genotypes: gmr>TDP43 is UAS-TDP-43/+; gmr-GAL4(YH3)/+. gmr>TDP-43+U12 RNAi is UAS-TDP-43/
UAS-snRNA:U12:73B.RNAiHMC03841; gmr-GAL4(YH3)/+.
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(c) Quantification of retina thickness related to Fig 2b. Three flies of each genotypes
were measured (n=3). Bars represent mean (SD). (*) P <0.05 (Two-tailed unpaired
Student’s t test). Genotypes are the same as indicated in Fig. 2b. (A.U.) arbitrary units.
(d) Schematic illustrates detection of spliced or unspliced products by RT-qPCR for a
U12-type intron.
(e) RT-qPCR analysis shows that spliced products of CG15735, CG16941, CG11839
are up-regulated by TDP-43 expression driven by daGS in fly heads, and
downregulation of Ell rescues the increased levels, while the unspliced products are not
changed significantly upon TDP-43 expression. RU486 (4 mg/ml) was used to induce
expression for 8d. mRNA levels were normalized to RpL32 mRNA. n=6 biological
replicates. Bars represent mean (SD). (*) P <0.05, (****) P<0.0001 (One-way ANOVA
followed by Tukey’s multiple comparison test). Genotypes are as indicated in Fig. 2a.
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Figure 3. TDP-43 and Lilli co-localize at the 93D locus on polytene chromosomes
(a) Immunostainings of DAPI (white), TDP-43-YFP (green) and Lilli (magenta) show
partial overlap of TDP-43-YFP and Lilli on chromosomes from salivary glands
expressing TDP-43-YFP. Sixteen sites of consistent co-localization are indicated
(bottom, see also Supplementary Table 1).
(b) Upon heat shock, Lilli localizes to major heat shock loci and co-localizes with TDP43-YFP at the 93D locus (enlarged at the upper right corner). See also Supplementary
Table 2.
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For (a) and (b), scale bars: 10 μm. Genotype: sgs3-GAL4/UAS-TDP-43-YFP.
(c) Venn diagram illustrates the numbers of genes bound by TBPH and Lilli.
(d) A ChIP-seq profile of TBPH (top, blue) and Lilli (bottom, orange) shows overlap at
the Hsrω transcription start site. Bar intervals indicate called peaks in TBPH (light blue,
top) and Lilli (light orange, bottom). The TBPH profile is one of four biological replicates
that show called peaks at Hsrω transcription start site.
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Figure 4. Hsrω is elevated and contributes to TDP-43 toxicity
(a) RT-qPCR analysis of fly heads shows that expression of TDP-43 driven by a druginducible promoter daGS leads to an increase of total Hsrω and Hsrω-n. Knockdown of
Ell reduces the elevated levels of total Hsrω and Hsrω-n. RU486 (4 mg/ml) was used to
induce expression for 4d. Relative RNA levels were normalized to Pgk, RpL32 and
RpS20 mRNAs (geometric mean). n=3 biological replicates. Bars represent mean (SD).
(*) P <0.05, (**) P <0.01, (***) P <0.001 (One-way ANOVA followed by Tukey’s multiple
comparison test). Genotype: daGS>TDP-43 is daGS-GAL4/+; UAS-TDP-43/+.
daGS>TDP-43+Ell RNAi is daGS-GAL4/+; UAS-TDP-43/UAS-Ell.RNAiHMS00277.
(b) Images of external eyes (top) and internal retina (bottom) show that loss of one copy
of Hsrω ameliorates TDP-43-caused eye degeneration. Scale bars: external eye, 100
μm; internal retina section, 5 μm. Genotypes: gmr>TDP-43 is UAS-TDP-43/+; gmrGAL4(YH3)/+. gmr>TDP-43+Hsrω+/- is UAS-TDP-43/+; gmr-GAL4(YH3)/Hsrω66.
(c) Quantification of retina thickness related to Fig 4b. Three flies of each genotypes
were measured (n=3). Bars represent mean (SD). (**) P <0.01 (Two-tailed unpaired
Student’s t test). Genotypes are the same as indicated in Fig. 4b. (A.U.) arbitrary units.
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Figure 5. Sat III is upregulated in a human cell model and FTD patient samples
(a) RT-qPCR analysis shows that the levels of Sat III are increased in HEK293 cells
expressing GFP-TDP-43 after 6d induction. Relative RNA levels were normalized to
GAPDH and ACTB mRNAs (geometric mean). n=6 biological replicates. Bars represent
mean (SD). (****) P<0.0001 (Two-tailed unpaired Student’s t test with Welch’s
correction).
(b) RT-qPCR analysis shows that the levels of Sat III are increased significantly in frontal
cortex of FTD patients compared to normal frontal cortex controls. Relative RNA levels
were normalized to GAPDH and ACTB mRNAs (geometric mean). All FTD patients had
TDP-43 pathology (FTLD-TDP). Case numbers and details are as indicated in Table 1.
Bars represent mean (SD). (**) P<0.01 (Two-tailed unpaired Student’s t test with Welch’s
correction).
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Figure 6. TDP-43 interacts with ELL2 in human cells
(a) RT-qPCR analysis of fly heads shows that expression of TDP-43 driven by daGS
leads to an increase of Ell. RU486 (4 mg/ml) was used to induce expression for 4d.
Relative RNA levels were normalized to Pgk, RpL32 and RpS20 mRNAs (geometric
mean). n=3 biological replicates. Bars represent mean (SD). (**) P <0.01 (Two-tailed
unpaired Student’s t test). Genotypes are the same as indicated in Fig. 4a.
(b) RT-qPCR analysis shows that the levels of ELL and ELL2 are increased in HEK293
cells expressing GFP-TDP-43 compared to cells expressing GFP after 6d induction.
Relative RNA levels were normalized to GAPDH and ACTB mRNAs (geometric mean).
n=6 biological replicates. Bars represent mean (SD). (****) P<0.0001 (Two-tailed
unpaired Student’s t test).
(c) IP with anti-TDP-43 antibody or mouse IgG as negative control followed by
immunoblotting studies with anti-ELL, ELL2 or TDP-43 antibody show that TDP-43
interacts with ELL2. The co-IP assays were repeated independently four times and show
consistent results (a different ELL2 antibody was used for detection for two repeats of
the experiments).
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Figure 7. TDP-43 promotes the levels of the targets of LEC and SEC contributing
to neurodegeneration
A model for TDP-43 toxicity associated with LEC and SEC. LEC regulates the
transcription of snRNAs, forming spliceosomes, and SEC regulates stress response
genes, maintaining cell homeostasis. In the disease state, TDP-43 promotes the levels
of LEC and SEC targets through interactions with Ell in fly/ELL2 in human cells,
including U12 and Hsrω/Sat III, leading to misregulation of splicing, cell loss and
disruption of cell homeostasis and contributes to neurodegeneration.
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Tables
Table 1. Human brain samples
Number
Normal controls

FTD
(FTLD-TDP)

No mutation identified

6

No mutation identified

6

GRN mutation

5

C9Orf72 mutation

1

VCP mutation

1
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Supplementary Information
Supplementary Table 1. Quantification of co-localization of TDP-43-YFP and Lilli
on 16 sites in 4 polytenes, related to Figure 3.
Chromosome

X

~Cytological
bands
2E
3F
15C
17C
18B

Polytene 1

Polytene 2

Polytene 3

Polytene 4

+
+
+
+
+

+
?
+
+
+

+
+
+
+
+

+
+
+
+
+

+
+
+
+
+
+ (weak)
+ (weak)
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
?
+
+ (weak)
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+

2L
2R

3L

3R

43E
48A
60A/B
61C
62A
74 EF
75CD
82D
93D
95F
100C

(+) co-localization, (?) unable to define due to pattern of chromosome spreading.
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Supplementary Table 2. Quantification of co-localization of TDP-43-YFP and Lilli
on 6 major heat shock loci in 15 polytenes, related to Figure 3.
Major heat shock loci
Polytene 1
Polytene 2
Polytene 3
Polytene 4
Polytene 5
Polytene 6
Polytene 7
Polytene 8
Polytene 9
Polytene 10
Polytene 11
Polytene 12
Polytene 13
Polytene 14
Polytene 15

63B
+ (weak)
+ (weak)
+ (very week)
+ (weak)
+ (weak)
+ (weak)
+
+ (very weak)
+ (very weak)
-

67B
+ (weak)
+
+ (weak)
-

(+) co-localization, (-) no co-localization.

66

93D
+
+
+
+
+
+
+
+ (weak)
+
+
+
+
+
+
+

95D
-

87A
-

87C
-

Supplementary Table 3. Fly lines.
Insertion
chromosome(s)
1
3
2
3
3
2
3
3
3
2
2
3
3
3
3
3
2
3
2
2
2
3
2
2

Fly lines
w1118
UAS-TDP-43-YFP
UAS-TDP-43
UAS-TDP-43
elavGS-GAL4
daGS-GAL4
da-GAL4
gmr-GAL4(YH3)
sgs3-GAL4
UAS-LacZ
lilli17-2
Hsrω66
UAS-EllP{EP}G4098
UAS-Ell.RNAiHMS00277
Ell[S-192]
UAS-ear.RNAiHMS00107
UAS-Ice1.RNAi (SH09112.N from DRSC/TRiP)
UAS-Ice1.RNAi (SH09113.N from DRSC/TRiP)
UAS-Ice1.RNAi (13550R-2 from NIG)
UAS-snRNA:U12:73B.RNAiHMC03841
UAS- Hsrω.RNAiHMC05093
UAS-Control.RNAiJF01355
UAS-(G4C2)48
UAS-mCherry RNAi

Reference/Source
Bloomington
37
37
37

Bloomington
140

Bloomington
37

Bloomington
Bloomington
Bloomington
Bloomington
Bloomington
Bloomington
Bloomington
Bloomington
This paper
This paper
NIG
Bloomington
Bloomington
Bloomington
147

Bloomington

Bloomington is to the Bloomington Drosophila Stock Center, https://bdsc.indiana.edu/
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Supplementary Table 4. Probes for small RNA Northern blot.
Name
U1
U2
U4
U4atac
U5
U7
U11
U12
2S

Sequence
5′-GATAATACGACTCACTATAGGGAGA-3′
5’-AAAAAACTGAGTTGACCTCTGCGATTATTCCTCTCCCTATAGTGAGTCGTATTATC-3′
5′-GATAATACGACTCACTATAGGGAGA-3′
5’-AAAAAATCGGCCTTATGGCTAAGATCAAATCTCCCTATAGTGAGTCGTATTATC-3′
5′-GATAATACGACTCACTATAGGGAGA-3′
AAAAAAGAAAACTTTAACCAATACCCCGCCTCTCCCTATAGTGAGTCGTATTATC-3′
5′-GATAATACGACTCACTATAGGGAGA-3′
5’-AAAAAATCAATGAACGTCTAGTGAGGACATTTCTCCCTATAGTGAGTCGTATTATC-3′
5′-GATAATACGACTCACTATAGGGAGA-3′
5’-AAAAAATCTGGTTTCTCTTCAATTGTCGAATTCTCCCTATAGTGAGTCGTATTATC-3′
5′-GATAATACGACTCACTATAGGGAGA-3′
5’-AAAAAACTCTTTGAAATTTGTCTTGGTGGGATCTCCCTATAGTGAGTCGTATTATC-3′
5′-GATAATACGACTCACTATAGGGAGA-3′
5’-AAAAAAGTTTCCGATCACGAAACTCAAGTGTCTCCCTATAGTGAGTCGTATTATC-3′
5′-GATAATACGACTCACTATAGGGAGA-3′
5’-AAAAAAAATGAGTAAGGAAAACCAATCAGCCTCTCCCTATAGTGAGTCGTATTATC-3′
5′-GATAATACGACTCACTATAGGGAGA-3′
5’-TGCTTGACTACATATGGTTGAGGGTTGTATCTCCCTATAGTGAGTCGTATTATC-3′

Two DNA oligonucleotides were annealed to obtain the template for each RNA probe.
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Supplementary Table 5. qPCR primers for Drosophila genes.
Name
Ell
Ear
Ice1
U12
CG6323
CG8408
CG16941
CG11839
CG7892
CG13431
CG33108
CG7736
CG17912
CG32705
CG11328
CG17228
CG15081
CG11984
CG4894
CG18177
CG15735
CG3294
CG16941 U12int
CG11839 U12int
CG33108 U12int
CG11328 U12int
CG15735 U12int
CG3294 U12int
Hsrω-all
Hsrω-n
βTub56D
Pgk
RpS20
RpL32

Forward Sequences (5’-3’)
AAAACAAACTCACATACAACCAAAAA
TTCCGAAACCCAAACGAGT
ACCACTTCCAGCCCTATGAG
TTTGCAAGGGCACAGGTC
TGCTCTTCTTCTACATGATCATTCTGTT
GTCGCCTACGTATTCCTGCAAACA
GCCGGAAGTTAGAAATATCGTTGAC
CACCATTGGCAAAGTATGACTCCTCG
CTTTCAAGAAATCTATGTGATAACGGAG
ATGGCCCAAATCCTTCTGGGATGA
GCCTACTAGTGCCCTACGATG
CCTCGAGGACACTATCAGCA
CCTCCAAACCCTGGTGCT
CGCCCATCGTAGCCATTATC
CGTTGAGCGATTTCTTCTCC
TGACGGCATGGCTCCTAC
AGAAGCCGAGGCTGCTAA
GCGAGCCGAATCTAGTCACA
ATTCGCATTGTGGAGTGG
GGCAAGGACGGATTCACCT
GGCCTTCGATCACAACACA
GAACTGCATGCCAAGAGG
ATGGCAACTTTAGACGCGGAA
GTTGTTTACACTTTCTAGCCGGTGT
GCATGTAGGTCCTTTGGACTG
TAACTCCCACCGCACATGA
GGCCTTCGATCACAACACA
GCGGTACGTGAACTGCAT
TATCTAATGTCCGGGGTCGT
ATAGTCCCTCGGAGGAAAGG
CATCCAAGCTGGTCAGTG
ATCACCAGCAACCAGAGAATTG
CCGCATCACCCTGACATCC
CATCCGCCCAGCATACAG

69

Reverse Sequences (5’-3’)
GCACTCGTTGTGGAAGTAGACA
CGTCTCGGTTGCGAAAGTA
GCTTCCCCACCAGGTTCT
GCTAGCCGGACGCAAAGTAG
GCACTTGTTTGCGCAAATCC
CCAGCGCCGAACAGAAACATATGA
ACTTTGGATTGCCCAGCTCA
CCACCTTATTCTGCTTAGCCTGATCG
GGATCTGGTACAGGAACACCTT
CCAAACGTGCGAGTGCGTGATATT
TGCGTGTCCACCAGATAACCTA
CCTTCATCTGCTTGACCTCATC
GGGTCCGGTGTACAACTTCTT
CATGTGGAAGCCGGTCAGT
TCGAACCCGAGTAAATTTGG
GGGATAGCGCACCCAGAA
TGCGTGCAATGCTTTGAG
GATGCGACGCACTCCAC
GTAAACAGCCAAGGCAATACAG
CATCGACGCGTAGTGCTTG
GTTGCCGTTGCACTCCTT
GGTGTACTCCAGTTCCGTGT
TTGTTTTCTTTTTGGCAAAGGATGC
GCCCGAGGAGTCATACGTATAGTTA
CAGTGTGCTGTTCACCGTTTAC
GGCCACCACACCAGTAAGTT
AGAAAGTGCTCGCTTTCACC
CAGTCGTTACCTTTGGGACA
CACAATCCGCACAATCAATC
GCGCTCACAGGAGATCAA
GCCA TGCTCATCGGAGAT
TGCCAGGGTGTACTTGATGTT
TGGTGATGCGAAGGGTCTTG
CCATTTGTGCGACAGCTTAG

Supplementary Table 6. qPCR primers for human genes.
Name
Sat III
GAPDH
ACTB
ELL
ELL2

Forward Sequences (5’-3’)
GTGCAATCGAATGGAATCG
CGAGATCCCTCCAAAATCAA
TTCCTGGGCATGGAGTC
GTCGGAGACGCCTGACTACT
TGGGAGCAATTCTGCAAC
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Reverse Sequences (5’-3’)
CCATTCCTGTACTCGGGTTG
TTCACACCCATGACGAACAT
CAGGTCTTTGCGGATGTC
TACTCGGCATTGAAGTCGTTC
ATCCAGGCCAGTCTCTTTGA
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Supplementary Figure 1. Downregulation of components in SEC and LEC
suppresses TDP-43-caused degeneration
(a) RT-qPCR analysis verifies that Ell, ear and Ice1 are knocked down by RNAi and Ell
is elevated by the upregulation fly line. RU486 (4 mg/ml) was used to induce the
expression of RNAi driven by daGS promoter. Whole flies were used for accessing
knockdown effects of Ell RNAi and Ice1 RNAi (8d RU486 induction), and upregulation
effect of Ell (1d). Larvae were collect for evaluate ear RNAi effect. Relative mRNA levels
were normalized to βTub56D mRNA. n=3 biological replicates. Bars represent mean
(SD). (**) P <0.01, (***) P <0.001 (Two-tailed unpaired Student’s t test with Welch’s
correction for RNAi effect; Two-tailed unpaired Student’s t test for upregulation effect of
Ell). Genotype: daGS>Ell RNAi is daGS-GAL4/+; UAS-Ell.RNAiHMS00277/+, Control for Ell
is da-GAL4/+, da>Ell is da-GAL4/UAS- EllP{EP}G4098, Control for ear is da-GAL4/mCherry
RNAi, da>ear RNAi is da-GAL4/UAS-ear.RNAiHMS00107, daGS>Ice1 RNAi is daGSGAL4/UAS-Ice1.RNAi (SH09112.N from DRSC/TRiP).
(b) Reduction of components involved in SEC and/or LEC on their own does not affect
eye integrity. Scale bars: 100 μm. Genotype: Control is gmr-GAL4(YH3)/+, gmr>Ell RNAi
is gmr-GAL4(YH3)/UAS-Ell.RNAiHMS00277, gmr>Ell is gmr-GAL4(YH3)/UAS-EllEPG4098,
gmr>ear RNAi is gmr-GAL4(YH3)/UAS-ear.RNAiHMS00107, lilli+/- is lilli17-2/+; gmrGAL4(YH3)/+ and gmr>Ice1 RNAi is UAS-Ice1.RNAi (SH09112.N from DRSC/TRiP)/+;
gmr-GAL4(YH3)/+.
(c) The levels of TDP-43 are unaltered by Ell RNAi, ear RNAi, loss a genomic copy of lilli
or upregulation of Ell. The levels of TDP-43 are elevated by Ice1 RNAi. n=3 biological
replicates. Bars represent mean (SD). (NS) not significant, (**) P <0.01 (Two-tailed
unpaired Student’s t test). Genotypes of the flies are the same as indicated in Fig. 1a, d.
(d) Western blot analysis of β-gal shows that the GAL4/UAS system is not altered by
downregulation of components in SEC and/or LEC. n=3 biological replicates. Bars
represent mean (SD). (NS) not significant (Two-tailed unpaired Student’s t test).
Genotypes: gmr>β-gal; Control is gmr-GAL4, UAS-β-gal/+, gmr>β-gal+Ell RNAi is gmrGAL4, UAS-β-gal/+; UAS-Ell.RNAiHMS00277/+, gmr> β-gal+ear RNAi is gmr-GAL4, UAS-βgal/+; UAS-ear.RNAiHMS00107/+, gmr> β-gal+lilli+/- is gmr-GAL4, UAS-β-gal/lilli17-2, gmr>
β-gal+Ice1 RNAi is gmr-GAL4, UAS-β-gal/UAS-Ice1.RNAi (SH09112.N from
DRSC/TRiP).
(e) Depletion of Ell and Ice1 by additional fly lines show the suppression effect on TDP43-mediated eye degeneration. The levels of TDP-43 and RNAi effect were confirmed by
western blotting and RT-qPCR. For RNAi effect confirmation, RU486 (4 mg/ml) was
used to induce the expression of RNAi driven by daGS promoter for 8 days. Genotypes:
gmr>TDP-43 is UAS-TDP-43/+; gmr-GAL4(YH3)/+. gmr>TDP-43+Ell+/- is UAS-TDP43/+; gmr-GAL4(YH3)/Ell[S-192]. gmr>TDP-43+Ice1 RNAi(NIG) is UAS-TDP-43/UASIce1.RNAi (13550R-2 from NIG); gmr-GAL4(YH3)/+. gmr>TDP-43+Ice1 RNAi(TRiP) is
UAS-TDP-43/+; gmr-GAL4(YH3)/UAS-Ice1.RNAi (SH09113.N from DRSC/TRiP).
daGS>Ice1 RNAi(NIG) is daGS-GAL4/UAS-Ice1.RNAi (13550R-2 from NIG) and
daGS>Ice1 RNAi(TRiP) is daGS-GAL4/+; UAS-Ice1.RNAi (SH09113.N from
DRSC/TRiP)/+.
(f) TDP-43 expression in the adult neurons by elavGS causes climbing defects, which
can be rescued by knockdown of Ell. Genotypes are as indicated in Fig. 1f.
(g) Knockdown of Ell on its own in neurons causes no climbing defects. Genotypes:
elavGS>Ell RNAi is elavGS-GAL4, UAS-Ell.RNAi HMS00277/+.
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For (f) and (g), RU486 (4 mg/ml) was used to induce the expression of TDP-43 and Ell
RNAi. EtOH was used as vehicle. 100 flies were measured 3 times for each genotype at
different time points. Bars represent mean (SD). (*) P <0.05, (**) P <0.01, (***) P <0.001,
(****) P<0.0001, (NS) not significant (Two-way ANOVA followed by Tukey’s multiple
comparison test). Significant differences are only indicated within the same time point.
(h) (I) Lifespan analysis of flies expressing TDP-43 and/or Ell RNAi by neuronal driver
elavGS (h) or ubiquitous driver daGS (I) show that Ell depletion mildly prolongs the
lifespan on its own and mildly extends the shortened lifespan mediated by TDP-43
expression. Genotypes are as indicated in Fig. 1f and Fig. 2a. n=200 flies per group. P
values are indicated in the figure (Log-rank test and Gehan-Breslow-Wilcoxon test).
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Supplementary Figure 2. Expression of TDP-43 affects the levels of selected
snRNAs and U12 intron-containing genes in fly heads
(a) Western blot analysis shows that downregulation of Ell does not alter TDP-43 protein
levels driven by ubiquitous drug-inducible diver daGS in fly heads. Genotypes of the flies
and RU486 treatment are the same as indicated in Fig. 2a, e.
(b) Northern blot analysis of Pol II-transcribed snRNAs shows that U2, U4atac, U5 and
U11 are not significantly affected by TDP-43 expression in fly heads. 2S rRNA was the
internal control. Genotypes of the flies and RU486 treatment are the same as indicated
in Fig. 2a, e.
(c) RT-qPCR analysis verifies that U12 is knocked down by RNAi. RU486 (4 mg/ml) was
used to induce the expression of RNAi for 8d, and whole flies were used. Relative
mRNA levels were normalized to RpL32 mRNA. Genotype: daGS>U12 RNAi is daGSGAL4/UAS-snRNA:U12:73B.RNAiHMC03841.
(d) Western blot analysis confirms that the levels of TDP-43 protein are not altered by
U12 RNAi. Genotypes of the flies are the same as indicated in Fig. 2b.
(e) Knockdown of U12 on its own does not affect eye integrity. Scale bars: 100 μm.
Genotype: Control is gmr-GAL4(YH3)/+ and gmr>U12 RNAi is UASsnRNA:U12:73B.RNAiHMC03841/+; gmr-GAL4(YH3)/+.
(f) RT-qPCR analysis of U12 intron-containing genes shows that 12 out of 18 genes are
not altered by TDP-43 expression in fly heads. Relative mRNA levels were normalized to
RpL32 mRNA. Genotypes of the flies and RU486 treatment are the same as indicated in
Fig. 2a, e.
For (a-d) and (f), n=3 biological replicates. Bars represent mean (SD). (*) P <0.05, (**) P
<0.01, (***) P <0.001, (NS) not significant (Two-tailed unpaired Student t test for
comparisons between 2 groups; One-way ANOVA followed by Tukey’s multiple
comparison test for comparisons among 3 groups).
(g) RT-qPCR analysis of 18 genes regulated by U12-dependent spliceosome shows that
both the spliced and unspliced products of CG33108, CG11328, CG3294 are upregulated by TDP-43 expression driven by daGS in fly heads, and downregulation of Ell
rescues the increased levels. RU486 (4 mg/ml) was used to induce expression for 8d.
mRNA levels were normalized to RpL32 mRNA. Statistical analysis and genotypes are
as indicated in Fig. 2a,e.
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Supplementary Figure 3. TDP-43 and Ell co-localize at the 93D locus on polytene
chromosomes
Immunostainings of DAPI (white), TDP-43-YFP (green) and Ell (magenta) show partial
overlap and co-localization of TDP-43-YFP and Ell on Hsrω locus in salivary glands
expressing TDP-43-YFP. Scale bars: 10 μm. Genotype is as indicated in Fig. 3a, b.
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Supplementary Figure 4. Controls for the specificity of Hsrω on TDP-43 toxicity
(a) Western blot analysis confirms that the levels of TDP-43 are not altered by
downregulation of Hsrω. n=3 biological replicates. Bars represent mean (SD). (NS) not
significant (Two-tailed unpaired Student t test). Genotypes are as indicated in Fig. 4b.
(b) Loss of one copy of Hsrω does not disrupt eye integrity. Scale bars: 100 μm.
Genotype: Control is gmr-GAL4(YH3)/+ and Hsrω+/- is gmr-GAL4(YH3)/Hsrω66.
(c) Depletion of Hsrω by an RNAi fly line suppresses the eye degeneration caused by
TDP-43 expression. The levels of TDP-43 and RNAi effect were confirmed by western
blotting and RT-qPCR. For RNAi effect confirmation, RU486 (4 mg/ml) was used to
induce the expression of RNAi driven by daGS promoter for 8 days, and whole flies were
used. Genotypes: gmr>TDP-43 is UAS-TDP-43/+; gmr-GAL4(YH3)/+. gmr>TDP43+Hsrω RNAi is UAS-TDP-43/UAS-Hsrω.RNAiHMC05093; gmr-GAL4(YH3)/+. daGS>Hsrω
RNAi is daGS-GAL4/UAS-Hsrω.RNAiHMC05093.
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Supplementary Figure 5. Sat III qPCR primers detect a large-fold induction by heat
stress
RT-qPCR analysis shows that the levels of Sat III are dramatically induced by heat
stress in HEK293 cells expressing GFP after 6d induction. Relative RNA levels were
normalized to GAPDH and ACTB mRNAs (geometric mean). n=6 replicates. Bars
represent mean (SD). (**) P<0.01 (Two-tailed unpaired Student’s t test with Welch’s
correction).
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Supplementary Figure 6. RNA levels and protein levels of ELL and ELL2 are not
altered in patient samples and a HEK293 cell disease model respectively
(a) RT-qPCR analysis shows that the levels of ELL and ELL2 are increased significantly
in frontal cortex of FTLD-TDP compared to normal frontal cortex controls. Bars represent
mean (SD). (NS) not significant (Two-tailed unpaired Student’s t test and Two-tailed
unpaired Mann-Whitney test for ELL; Two-tailed unpaired Student’s t test for ELL2).
Sample details are as indicated in Fig. 6b.
(b) Western blot analysis of ELL and ELL2 show that protein levels of ELL and ELL2 are
not altered in HEK293 cells expressing GFP-TDP-43 compared to cells expressing GFP
after 6d induction. GAPDH was used as internal control. n=4 biological replicates. Bars
represent mean (SD). (NS) not significant (Two-tailed unpaired Student t test).
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Supplementary Figure 7. The uncropped scans of western blots in Fig. 1g and Fig.
6c
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Supplementary Figure 8. The uncropped scans of small RNA Northern blots
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Supplementary Figure 9. Depletion of Ell suppresses the eye degeneration caused
by G4C2 expansion
Expression of GGGGCC expansion causes eye degeneration, which is suppressed by
Ell RNAi. Scale bars: 100 μm. Genotypes: Control is gmr-GAL4(YH3)/+. gmr>(G4C2)48 is
UAS-(G4C2)48/+; gmr-GAL4(YH3)/+. gmr>(G4C2)48+Control RNAi is UAS-(G4C2)48/+; gmrGAL4(YH3)/UAS-Control.RNAiJF01355. gmr>(G4C2)48+Ell RNAi is UAS-(G4C2)48/+; gmrGAL4(YH3)/UAS-Ell.RNAiHMS00277.
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Supplementary Data
File Name: Supplementary Data 1
Description: The lists of genes bound by TBPH, Lilli or both, derived from 69,114
(The file will be able to be downloaded from https://www.nature.com/ncomms/)
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CHAPTER 3: CONCLUSION AND FUTURE DIRECTIONS

CONCLUSION OF THE FINDINGS AND OPEN QUESTIONS
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Conclusions
Our work defined Ell, the shared subunit of LEC and SEC, as a strong dose-dependent
modifier of TDP-43-mediated degeneration by using a powerful Drosophila disease
model expressing human TDP-43 in the fly eye system (Figure 1a-c). The identification
of Ell was through a fly genetic screen for modifiers of TDP-43-mediated eye
degeneration. Other potential modifiers of TDP-43 toxicity indicated by the screen are
listed in Table 3.1 (derived from Ross Weber’s data). Depletion of the components
specific for LEC or SEC partially suppressed the eye degeneration, although the
suppression is not as strong as downregulation of the shared component Ell (Figure
1d,e). The ability to suppress TDP-43-mediated neurodegeneration was further
demonstrated in the fly nervous system (Figure 1f). These findings reveal the important
roles of Ell and Ell-containing complexes in TDP-43-mediated neurodegeneration, and
implicate misregulation of LEC and SEC in mechanisms of disease.

We sought evidence indicating that the activities of LEC and SEC were upregulated. By
Northern blot analysis, several LEC target snRNAs, including U1, U4, U7 and U12
snRNAs, were upregulated in fly heads with TDP-43 expression compared to controls
(Figure 2-2a). Among these, depletion of U12 snRNA functionally ameliorated eye
degeneration caused by TDP-43, indicating that the elevation of U12 contributes to TDP43-mediated degeneration (Figure 2b,c). Further examination of the levels of 18 genes
containing an intron regulated by the U12-dependent spliceosome showed that the
spliced products of 3 genes, CG15735, CG16941 and CG11839, are upregulated in fly
heads with expression of TDP-43, with the levels of the unspliced products unchanged
(Figure 2e). These results suggest that the activity of LEC might be upregulated, leading
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Table 3-1. Additional potential modifiers of TDP-43 toxicity
Gene Symbol
Gene (CG #)
Bloomington Stock #
E(bx)
CG32346
27471
pcm
CG3291
33263
SREBP
CG8522
27232
CG3542
CG3542
17291
CG7220
CG7220
29681
CG44837
CG44837
17283
CG16711
CG16711
27182
CG17187
CG17187
30066

Effect
Enhancer
Enhancer
Suppressor
Suppressor
Suppressor
Suppressor
Suppressor
Suppressor

Mnt; Parg
CG5009
Smyd5
bin3
RpS15
Ac76E

CG13316; CG2864
CG5009
CG3353
CG8276
CG8332
CG7978

10086
148
(P{EP}CG5009B227.2)
30047
22584
27125
17485

Suppressor
Suppressor
Suppressor
Suppressor
Suppressor
Suppressor

Top3α
Vha68-2
Vamp7

CG10123
CG3762
CG1599

17238
17243
28488

Suppressor
Suppressor
Suppressor

ppk5; Rpn10

CG33289; CG7619

27212

Suppressor

CG14182
CG6923
Hph
fus
CG11110
CG7530
CG5789
CG15771; lin-52

CG14182
CG6923
CG44015
CG8205
CG11110
CG7530
CG5789
CG15771; CG15929

27134
30077
20142
27457
27466
15762
17083
17004

Suppressor
Suppressor
Lethal
Lethal
Lethal
Lethal
Lethal
Lethal

S6KL; CG6961

CG7001; CG6961

10144

Lethal

CG6294; CG6299
RpI12; tsl

CG6294; CG6299
CG13418; CG6705

33456
32613

Lethal
Lethal

(The table is derived from Ross Weber’s data)
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to downstream abnormally elevated activity of the U12-dependent spliceosome,
contributing to TDP-43 toxicity.

A different approach was undertaken to define important targets of SEC. By Drosophila
polytene chromosome immunostaining under ambient and heat shock treatment, TDP43 and Lilli (the essential component of SEC) were discovered to colocalize on the
chromosomal locus of a stress-induced lncRNA Hsr⍵, suggesting that Hsr⍵ is a shared
target of TDP-43 and SEC (Figure 3a,b). Analyses of published ChIP-seq databases of
fly TBPH and Lilli 69,114 also showed that Hsr⍵ is a gene bound by both factors (Figure
3c,d). The levels of Hsr⍵ are increased in the fly disease model and Hsr⍵ was shown to
functionally contribute to TDP-43-mediated degeneration (Figure 4a-c). These data show
that TDP-43 co-localizes with central SEC components on the chromosomes, identifying
a novel non-coding lncRNA target of TDP-43 with functional importance to degeneration.

Our results suggest a model in which SEC and LEC contribute to TDP-43-meidated
degeneration in parallel. By comparing the retinal thickness in the fly disease model,
downregulation of the shared component Ell restored eye degeneration caused by TDP43 and caused a 4-fold increase in retinal thickness that was comparable to normal
retinal thickness. By contrast, depletion of LEC- and SEC-specific components led to
only a ~2-fold increase in retinal thickness, and depletion of downstream targets U12
and Hsr⍵ led to only ~1.5-fold increase in retinal thickness. Comparison of the retinal
thickness is shown in Figure. 3.1.
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Figure 3-1. Comparison of suppression
effects of downregulation of different factors
Analysis of retinal thickness shows that depletion
of the shared component Ell suppresses TDP-43mediated eye degeneration more strongly than
downregulation of LEC- or SEC-specific
components, or downstream targets.

The relevance of this stress-induced lncRNA in human disease was further assessed
using a human cell disease model and patient tissue. The levels of the human
counterpart of Hsr⍵, Sat III, in HEK cells expressing GFP-tagged TDP-43 was
upregulated ~4-fold compared to control (Figure 5a). Furthermore, the levels of Sat III
were increased significantly in frontal cortical tissues from FTD patients with TDP-43
pathology (FTLD-TDP) compared to tissue from normal individuals (Figure 5b). Since
upregulation of Sat III has been shown to promote cell death and acute senescence in
different cell models 119,120, these results suggest that stress-induced non-coding RNA
Sat III may be a contributor to TDP-43-mediated degeneration.

Given that ELL is the shared element of LEC and SEC, we sought to define how
disruption of ELL function may be induced by TDP-43. We found that TDP-43 physically
interacts one of the ELL orthologues in HEK293 cells by co-immunoprecipitation. We
were able to test ELL and ELL2, and found evidence that TDP-43 interacts in lysates
with human ELL2 (Figure 6c). Together with the immunostaining data showing that TDP43 co-localizes with SEC on polytene chromosomes, these results indicate that a
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mechanism contributing to the promotion of LEC and SEC activity may include
interaction between TDP-43 and the proteins of the complexes.

These findings reveal novel roles of the transcription elongation factor Ell-containing
complexes, highlight the importance of non-coding RNAs in disease, elucidate new
mechanistic insight into neurodegenerative disorders and provide therapeutic targets for
TDP-43-associated neurodegeneration.

Future directions
Targets of LEC and SEC
In the investigation of the targets of LEC and SEC, we used information from the
literature to define potential important targets and used different assays to examine the
role of these potential targets. Through these approaches, we identified important
targets, including U12 snRNA and Hsrw, that we showed are functionally involved in
TDP-43-mediated degeneration (Figure 2, 3 and 4). The relationship and interaction
between U12 and Hsrw in suppressing TDP-43 toxicity can be further dissected. One
interesting question is whether downregulation of one of these targets can affect the
levels of the other. This can be addressed by assessing the levels of U12 and Hsrw in fly
head tissue upon downregulation of U12 or Hsrw.

In addition to the identified targets U12 and Hsrw , there may be other targets regulated
by LEC and SEC that are critical in disease. In addition, in previous studies, targets of
LEC and SEC were identified and investigated in non-neuronal cells, including
Drosophila S2 cells 69, mouse embryonic cells73, human HCT-116 cells 72 and human
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HEK cells 74. It is therefore unknown the extent to which the targets of LEC and SEC are
the same in the nervous system. Given the suppression effect of LEC and SEC
downregulation on TDP-43-mediated neurodegeneration (Figure 1), identifying the
protein-coding and non-coding RNA targets of LEC and SEC in neurons, as well as
revealing the targets important in neurodegenerative situations may help us understand
the roles of LEC and SEC in the nervous system and in TDP-43 toxicity more
thoroughly.

To define the global targets of LEC and SEC in the nervous system and identify
important genes in TDP-43 toxicity, I propose to use ChIP-seq complemented with RNAseq to identify genes bound by different factors and detect the transcriptomic changes
under different conditions. ChIP-seq can be conducted using antibodies against Ell (the
shared component), Ice1 (specific to LEC) and Lilli (specific to SEC) and TDP-43, in fly
brains/heads with or without TDP-43 expression. Targets of LEC are predicted to be
those bound by Ell and Ice1, while targets of SEC are predicted to be those bound by Ell
and Lilli. Comparisons of LEC or SEC targets in TDP-43 expressing animals to controls
are predicted to elucidate whether LEC or SEC bind to different sets of genes in the fly
disease model compared to the normal condition.

RNA-seq can be used to analyze and compare the transcriptome in fly heads or brains
with the combination of TDP-43 expression, depletion of Ell (the shared component),
Ice1 (specific to LEC) and Lilli (specific to SEC) (Table 3-2). By comparing Group 1 and
2, gene alterations caused by TDP-43 expression can be identified. This analysis would
also improve our understanding of this fly disease model. The LEC-regulated genes in
fly brain are predicted to be downregulated in both Group 3 and 5, compared to Group 1.
91

The SEC-regulated genes will be those downregulated in Group 3 and 7 compared to
Group 1. Important targets of LEC in disease are predicted to be those upregulated in
Group 2 and rescued in Group 4 and 6. Likewise, potential important targets of SEC are
those upregulated in Group 2 and decreased back toward normal in Group 4 and 8.
Defined target genes then can be further analyzed for confirmation and functional
importance using fly and human cell disease models. Alternatively, to reduce the
complexity and numbers of samples, RNA-seq could be done focusing only the
combinations of TDP-43 expression and Ell downregulation. The involvement of Ice1
and Lilli could be assessed by ChIP-qPCR later once specific genes are identified. The
best time point and conditions for sample collection would require determination by pilot
studies using target genes identified in this thesis work, such as U12 and Hsrw.
Table 3-2. Experimental design for identification of global LEC and SEC targets
Group
1
2
3
4
5
6
7
8
TDP-43
+
+
+
Ell RNAi
+
+
Ice1 RNAi
+
+
Lilli RNAi
+
+

Does Ell, U12 or Hsrw affect stress sensitivity?
TDP-43 expressing flies show hypersensitivity to heat stress, paraquat-induced oxidative
stress and starvation 103. In my thesis, we show that the heat shock-induced lncRNA
Hsrw is aberrantly upregulated in fly heads with TDP-43 expression. These data suggest
that the stress response may be misregulated in these animals. Environmental stress
can be broadly defined as environmental changes that threaten or disrupt physiological
homeostasis and reduce the performance or fitness of the organism 149,150. The effect of
stress on an organism depends on the type of stressor, the stress intensity and duration,
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and different situations may trigger different stress responses 151. Therefore, it is likely
that TDP-43 expressing animals may react differently according to the specific stress
situation 151,152.

A question we have is whether the suppression effect of depletion of Ell, U12 or Hsrw on
TDP-43-mediated degeneration is through modulating the stress response. To test this
hypothesis, one can start from assessing sensitivity of flies to a variety of stress
situations with TDP-43 expression combined with downregulation of Ell, U12 and Hsrw.
The prediction is that expression of TDP-43 may lead to altered sensitivity to different
stressors and stress situations, and depletion of Ell, U12 and may rescue the affected
stress sensitivity.

Is transcriptional pausing regulation affected?
Misregulation of transcriptional elongation has been associated with different diseases,
including cancer, virus infection and developmental diseases 79,82,123. Yet very little was
known about its involvement in neurodegenerative diseases prior to this work. Our study
suggests a model of abnormal activation of LEC and SEC in TDP-43-mediated
neurodegeneration (Figure 2-7). This predicts that transcription pausing regulated by
LEC and SEC is misregulated. This idea is supported by our data showing targets of
LEC and SEC are upregulated in the disease models (Figure 2-2 and 2-4). However, to
further strengthen and prove this hypothesis, direct evidence of dysfunction of
transcriptional pausing regulation is required.
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The regulation of transcription elongation in TDP-43-mediated degeneration can be
assessed for specific targets or investigated globally by different assays in the disease
models used in this study. The stress-induced lncRNA Hsrw regulated by SEC is defined
as a novel target of TDP-43 (Figure 2-3 and 2-4), and this specific gene can be an
interesting target for accessing pausing regulation. I propose to use ChIP-qPCR with
antibody against total Pol II and qPCR primers to detect Pol II occupancy on Hsrw gene
at either the transcriptional start site (~0), pausing region (~+30) or intergenic regions as
a control. A second method, permanganate (KMnO4) footprinting, can also be used to
assess pausing regulation on Hsrw. Paused and transcriptionally engaged Pol II leads to
single-stranded DNA regions, where potassium permanganate can oxidize thymines.
The oxidized thymines can then be cleaved, and the positions of DNA breaks can be
determined by ligation-mediated PCR (LM-PCR) using primers specific to Hsrw.

The genome-wide identification of pausing regulation in TDP-43 disease models can be
assessed by precision nuclear run-on sequencing (PRO-seq) 153 by using 1) nuclei
isolated from fly heads with or without TDP-43 expression 2) nuclei isolated from HEK
cells with GFP-TDP-43 expression or GFP expression. In PRO-seq, isolated nuclei are
treated with Sarkosyl, which prevents new incorporation of Pol II into the chromosomes,
and used for identification of sites with transcriptional-engaged Pol II by extending
nascent RNAs with biotin-labeled ribonucleotide triphosphate analogs (biotin-NTP). By
comparing the Pol II active sites in the fly and human cells with TDP-43 expression to
controls, any alterations to transcriptional pausing regulation on coding and non-coding
genes can be revealed.
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Ell as a universal therapeutic target
in neurodegenerative diseases?
In ALS and FTD, another important
disease factor is the GGGGCC (G4C2)
hexanucleotide repeat expansion.
Over the last 7 years, a G4C2
hexanucleotide repeat expansion in
the 5’ region of C9ORF72 has been
identified as the most common

Figure 3-2. Ell depletion suppresses the
toxicity of G4C2 expansion
Lifespan assay show that Ell depletion extends
the lifespan of flies with G4C2 repeat expression.

genetic mutation in ALS and FTD 130,131. Expression of transgenes bearing a G4C2
hexanucleotide repeat expansion in the fly causes neurodegeneration 147,154-156. In our
study, Ell was identified as a strong dose-dependent modifier of TDP-43 toxicity (Figure
2-1). Given that ALS and FTD are within the same disease spectrum and share
molecular features, we tested the effect of Ell downregulation on fly eye degeneration
caused by expression of G4C2 hexanucleotide repeat expansion. The results show that
Ell depletion also markedly ameliorates toxicity of G4C2 hexanucleotide repeat expansion
(Figure 2-S9). In additional preliminary results, the suppression effect of Ell
downregulation on G4C2 hexanucleotide repeat expansion toxicity in a lifespan assay
was also observed, by using the drug-inducible ubiquitous daGS promoter (Figure 3-2).
Although a modest effect, the impact on lifespan is rigorous when compared with
controls (Figure 3-2). These data suggest that shared targets of Ell might be critical to
degeneration associated with these two disease factors.

Moreover, my data indicate that different neurodegenerative diseases beyond ALS and
FTD might share similar pathways. Neurodegenerative diseases accord common
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pathogenetic mechanisms involving aggregation of misfolded proteins, as with Tau and
Amyloid-beta (Aβ) in Alzheimer’s disease, α-Synuclein in Parkinson’s disease,
Huntingtin in Huntington and TAR DNA binding protein 43 (TDP-43) in ALS and FTLDTDP 157,158. Although the type of disease proteins and the cellular and regional
distribution of aggregates are varied among the diseases, similar biological and genetic
pathways may link these disorders. To assess the involvement of Ell in other
neurodegenerative diseases associated with additional toxic proteins, the effect of Ell
downregulation was examined in fly disease models expressing Tau and Aβ in the fly
eye. Expression of Tau and Aβ driven by the eye specific driver gmr led to eye
degeneration that was be suppressed by Ell depletion (Figure 3-3).
Figure 3-3. Depletion of Ell suppressed the toxicity of Tau and Aβ
External eye images show that expression of Tau and Aβ cause eye
degeneration, which are ameliorated by Ell downregulation.

These preliminary data suggest that Ell might be a central factor among a range of
different toxicities associated with different neurodegenerative proteins. To identify the
common and distinct coding and noncoding targets of Ell in different disease models
may provide effective therapeutic insight. Before further addressing the potential central
96

role of Ell in neurodegeneration, one should clarify whether the suppression effects of Ell
are through decreasing the levels of the disease factors. The reason for this is that Ell
might play different roles in mechanisms associated with different disease factors. For
example, depletion of a transcriptional elongation factor Spt4 has been shown to
decrease the transcripts of expanded G4C2 repeats 159. Potentially, downregulation of Ell,
which is also involved in the regulation of elongation, could also affect the production of
G4C2 repeat transcripts and therefore suppress the toxicity associated with the repeat
expansion.

Next, to identify the important targets of Ell in different disease models, I propose to test
the toxicity of disease factors and the suppression effect of Ell carefully by the druginducible ubiquitous driver daGS using lifespan and other assays. RNA-seq can then be
used to compare the transcriptomes in fly heads/brains with the combination of
expression of different disease factors and Ell RNAi (Table 3-3). Transcriptome changes
in different disease models can be identified by comparing Group 2, 5 or 7 to Group 1.
Important Ell targets that are common in all disease models are predicted to be
upregulated in Group 2, 5, and 7 and downregulated in Group 4, 6 and 8. Furthermore,
critical Ell targets that are specific for each disease factor can also be identified by
comparing changes among the different groups. To reduce complexity, it may be
impactful to start from TDP-43 and G4C2 hexanucleotide repeat expansion, which are
two distinct factors but important for the same disease spectrum of ALS/FTD.
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Table 3-3. Experimental design for identification of common and distinct Ell
targets
Group
1
2
3
4
5
6
7
8
TDP-43
+
+
G4C2
+
+
Tau or Aβ
+
+
Ell RNAi
+
+
+
+
Can Sat III affect TDP-43 LLPS or aggregation?
Our work identified the Drosophila stress-induced lncRNA Hsrw, which is upregulated in
a fly disease model, as a novel modifier of TDP-43-mediated degeneration (Figure 2-3,
2-4). Furthermore, human orthologue Sat III repeats are abnormally elevated in a human
cellular model and frontal cortical tissue from FTD patients with TDP-43 pathology
(Figure 2-5). One question is how elevated Sat III may contribute to TDP-43-mediated
toxicity. TDP-43, containing a low complexity domain, forms aggregates in neurons and
glia of ALS and FTLD-TDP patients 9,10, and purified TDP-43 can undergo liquid liquid
phase separation (LLPS) and form aggregates in vitro 160,161. Many of the diseaseassociated TDP-43 mutations promote TDP-43 aggregation in disease models,
suggesting formation of inclusions may be causal to the TDP-43-associated
dysfunction162,163.

Distinct from other stress genes, the Sat III RNAs form a transient subnuclear organelle,
the nuclear stress body (nSB), which is associated with the site of Sat III DNA; the
comparable structure in Drosophila is the omega speckle 106,108,109. Our data show that
TDP-43 localizes to the Hsrw locus (Figure 2-3), suggesting that TDP-43 may also bind
the w speckle. In fact, TDP-43 has been reported to localize to nSB under heat shock in
HeLa cells 164, suggesting that Sat III may interact with TDP-43. Thus, it may be that
highly repetitive Sat III RNAs increase the local concentration of various RNA-binding
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proteins, including TDP-43, and promote LLPS to form nSB. These data lead us to
hypothesize that there might exist a feedback loop between TDP-43 and Sat III: in
disease, TDP-43 expression leads to the elevation of Sat III levels, which in turn
contributes to TDP-43-mediated toxicity by promoting TDP-43 LLPS and/or aggregation,
potentially in the nSB.

LLPS has been proposed to be a dynamic process that gives rise to membrane-less
organelles 165,166, and RNAs have been shown to regulate LLPS 167-169. As one test of this
hypothesis, Sat III generated by in vitro transcription can be added to TDP-43, and LLPS
and aggregation can be measured using different concentrations of RNA and protein to
assess whether Sat III can alter TDP-43 droplet formation or aggregation. Sat III by itself
can also be tested for LLPS. These in vitro assays can test the hypothesis and might
provide more mechanistic insights for the findings from the in vivo studies.

Conclusion
Our studies have defined a critical role for ELL in toxicity of TDP-43. Importantly, the
ELL regulated pathway may be broad, and the future directions proposed seek to define
those pathways in greater detail, as well as define the specific mechanisms of the
pathways revealed in this thesis with greater clarity.
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